'Pfizer' is featured as a movie character in the following productions:
Contagion (2011)
Actors:
Steven Soderbergh (actor),
Walt Sloan (actor),
Laurence Fishburne (actor),
Jude Law (actor),
Elliott Gould (actor),
Armin Rohde (actor),
Bryan Cranston (actor),
David Cohen (actor),
Don Kress (actor),
Shannon Edwards (actor),
Andrew Dasz (actor),
John Hawkes (actor),
Matt Damon (actor),
Amanda Dyar (actress),
Marion Cotillard (actress),
Plot: Soon after her return from a business trip to Hong Kong, Beth Emhoff dies from what is a flu or some other type of infection. Her young son dies later the same day. Her husband Mitch however seems immune. Thus begins the spread of a deadly infection. For doctors and administrators at the U.S. Centers for Disease Control, several days pass before anyone realizes the extent or gravity of this new infection. They must first identify the type of virus in question and then find a means of combating it, a process that will likely take several months. As the contagion spreads to millions of people worldwide, societal order begins to break down as people panic.
Keywords: admiral, adulteress, airplane, airport, ambulance, american-abroad, apartment, atlanta-georgia, australian, autopsy
Genres:
Drama,
Sci-Fi,
Thriller,
Taglines: The world goes viral September 9 Don't talk to anyone. Don't touch anyone. Nothing spreads like fear
Quotes:
Dr. Ian Sussman: [Disparagingly to Alan] Blogging is not writing. It's just graffiti with punctuation.
Alan Krumwiede: It's a bad day to be a rhesus monkey.
Dr. Ellis Cheever: Someone doesn't have to weaponize the bird flu.The birds are doing that.
Dr. Ellis Cheever: When was the last time you ate something that didn't come from a vending machine?::Dr. Erin Mears: [Hesitantly] Taco Bell
Alan Krumwiede: Godzilla, King Kong, Frankenstein all in one.
Dave: My wife makes me take off my clothes in the garage. Then she leaves out a bucket of warm water and some soap. And then she douses everything in hand sanitizer after I leave. I mean, she's overreacting, right?::Dr. Erin Mears: Not really. And stop touching your face, Dave.
Jory Emhoff: [Rhetorically] Why can't they invent a shot that keeps time from passing?
First Haz-Mat: [Putting a body in a mass grave] When did we run out of body bags?::Second Haz-Mat: Two days ago.
Gall Force: The Revolution (1996)
Actors:
Ai Orikasa (actress),
Kikuko Inoue (actress),
Kotono Mitsuishi (actress),
Michiko Neya (actress),
Chisa Yokoyama (actress),
Urara Takano (actress),
Kyôko Hikami (actress),
Tomo Sakurai (actress),
Hideki Kakinuma (writer),
Fumie Kusachi (actress),
Moe Nagasaki (actress),
Hiroshi Fukishima (director),
Genres:
Action,
Animation,
Drama,
Sci-Fi,
-
Hillary Clinton blasts Pfizer-Allergan deal
The Weekly Standard Executive Editor Fred Barnes and Fox News contributor Julie Roginsky on the Pfizer-Allergan deal, corporate taxes in the U.S. and the top issues in the 2016 presidential race.
Watch Liz Claman talk about Elections on Closing Bell.
-
Clinton, Sanders bash mega merger between Pfizer, Allergan
Say taxpayers will be left holding the bag
Watch Gary B Smith and Neil Cavuto talk about Democrats, Elections, Finance, Presidential Primaries, and Taxes on Your World.
-
How Pfizer Is Going To Rob You
Pharmaceutical giant Pfizer is planning on merging with a counterpart in Ireland called Allergan. Critics are pointing out that if this merger is successful, it could save Pfizer a lot in taxes. Corporations like to base their company in Ireland because of their low corporate tax rate. The merger could cost American tax payers millions. Cenk Uygur and Ana Kasparian (The Point) hosts of The Young T
-
Inside Pfizer, Allergan's Record $160B Deal
Nov. 23 -- Pfizer Inc. and Allergan Plc said they would combine operations in a stock transaction worth about $160 billion, creating a drugmaking behemoth with products from Viagra to Botox and a low-cost tax base. Jefferies Chief Market Strategist David Zervos and Bloomberg's Cynthia Koons speak on "Bloomberg ‹GO›."
-
Pfizer to buy Allergan in $160bn deal
The US drug giant Pfizer, has sealed a deal to buy European-based group Allergan.
The one hundred and sixty billion dollar deal will be the largest pharmaceutical takeover in history.
It will allow Pfizer to move its headquarters to Ireland to escape high US corporate taxes.
Al Jazeera's Alan Fisher reports on how the move has been criticised by some.
Subscribe to our channel http://bit.ly/AJ
-
Pfizer's Read on How Tax Code Harms Company
Pfizer CEO Ian Read explains how the pharmaceutical company is at a competitive disadvantage as a consequence of the U.S. tax code at the WSJ Viewpoints Executive Breakfast Series.
Subscribe to the WSJ channel here:
http://bit.ly/14Q81Xy
More from the Wall Street Journal:
Visit WSJ.com: http://www.wsj.com
Follow WSJ on Facebook: http://www.facebook.com/wsjvideo
Follow WSJ on Google+: https://pl
-
Q. Why do you work at Pfizer?
Laurie Olson, head of Pfizer’s Strategy, Portfolio, and Commercial Operations group, talks Laurie Olson, EVP Strategy and Portfolio, talks about why she works at Pfizer and what inspires her to come to work every day.
-
Pfizer CEO on Potential for a Spinoff
At the WSJ Viewpoints Executive Breakfast Series, Pfizer CEO Ian Read discusses the potential for the company to spin off a portion of its business.
Subscribe to the WSJ channel here:
http://bit.ly/14Q81Xy
More from the Wall Street Journal:
Visit WSJ.com: http://www.wsj.com
Follow WSJ on Facebook: http://www.facebook.com/wsjvideo
Follow WSJ on Google+: https://plus.google.com/+wsj/posts
Follow
-
Pfizer -- Largest Pharmaceutical Company In The World
The New York-based giant is one of the largest pharmaceutical companies in the world, based on revenues. Known for famous drugs like Lipitor and Viagra, Pfiz...
-
Pfizer Corporate VDO
http://www.going2mars.com http://www.facebook.com/go2mars.
-
Will regulators try to block the Pfizer-Allergan deal?
JPMorgan Global Head of Equity Strategy Steven Rees on Pfizer and Allergan reaching a deal to merge.
Watch Dagen Mcdowell and Maria Bartiromo talk about Investing Basics on Mornings With Maria.
-
Graffiti - Pfizer commercial
There is more than a medication!
-
Pfizer, Allergan Lead In Busy Year for Mergers
Drug makers Pfizer and Allergan have confirmed they are in talks for a possible merger, in what could be the latest deal in year marked by major mergers and acquisitions. Photo: AP
Subscribe to the WSJ channel here:
http://bit.ly/14Q81Xy
More from the Wall Street Journal:
Visit WSJ.com: http://www.wsj.com
Follow WSJ on Facebook: http://www.facebook.com/wsjvideo
Follow WSJ on Google+: https://pl
-
Behind Pfizer’s takeover of Allergan | Lex
► Subscribe to the Financial Times on YouTube: http://bit.ly/FTimeSubs
Pfizer on Monday announced the biggest healthcare deal in history by agreeing to acquire Dublin-based Allergan. Lex’s Oliver Ralph and Robert Armstrong discuss what this deal entails for Pfizer and why its shares have not gone up yet.
For more video content from the Financial Times, visit http://www.FT.com/video
Twitter htt
-
Pfizer-Allergan $160 billion merger sparks debate
U.S. pharmaceutical giant Pfizer is buying Botox maker Allergan for 160 billion dollars. But size isn't everything. The deal involves Pfizer shifting its headquarters to Ireland and that means it can slash its tax bill.
It has stoked a very contentious debate here in the U.S. and looks set to be a big issue in the presidential election. CCTV America's Shraysi Tandon reports.
-
Pfizer Tour
Portage and Kalamazoo government officials tour Pfizer's production facility, Building 41, in Portage Michigan. Video by Mark Bugnaski - Kalamazoo Gazette - ...
-
Our Immune System - Pfizer - Cortical Studios / Glow Studio
"Our Immune System," is an award-winning movie commissioned by Pfizer BV, that shows the complexity of inflammation and autoimmune diseases. In a joint effor...
-
Botox, Viagra or Placebo?: The Pfizer Allergan Deal
Pfizer is planning to buy Allergan in a mega-deal, motivated by two factors: the desire to buy growth (which it sorely lacks) and move out of US tax jurisdiction. In this webcast, I look at both but spend most of my time assessing the value effect of the tax code
Slides: http://www.stern.nyu.edu/~adamodar/pdfiles/blog/PfizerDeal.pdf
Spreadsheet: http://www.stern.nyu.edu/~adamodar/pc/blog/PfizerInv
-
Protecting Viagra: Inside Pfizer's Fake Drug Lab
April 8 (Bloomberg) -- Boric acid, lead paint, sheet rock are just some of the ingredients found in counterfeit pills sold online. Bloomberg's Olivia Sterns ...
-
Pfizer Comercial Viagra
-
Pfizer: Lead by Example
President of Pfizer Consumer Healthcare, Paul Sturman, discusses his background and management style "At the Top".
-
Pfizer CEO testifies before UK parliamentary Panel
Bloomberg has the ownership of this material. It's posted here just for educational purposes. Is the french "idée" of democracy much more effective than in t...
-
TEUTO Pfizer - Documentário Institucional
Cliente: Laboratório TEUTO Brasileiro
Agência: Agência A Propaganda
Material: Institucional
Atendimento: Vera Joy, José Veloso
Planejamento: Lucas Santos e Marisa Rodrigues
Mídia: Gláucia Sousa
Redação: Raoni Henrique e Francine Souza
Direção de Criação: Jonathas Veloso
Direção de Arte: Marcel Diego e Rafael Freitas
Web: Paulo Rosarf
Produtora: 30 Segundos Filmes
Direção do filme: Jonathas V
Hillary Clinton blasts Pfizer-Allergan deal
The Weekly Standard Executive Editor Fred Barnes and Fox News contributor Julie Roginsky on the Pfizer-Allergan deal, corporate taxes in the U.S. and the top is...
The Weekly Standard Executive Editor Fred Barnes and Fox News contributor Julie Roginsky on the Pfizer-Allergan deal, corporate taxes in the U.S. and the top issues in the 2016 presidential race.
Watch Liz Claman talk about Elections on Closing Bell.
wn.com/Hillary Clinton Blasts Pfizer Allergan Deal
The Weekly Standard Executive Editor Fred Barnes and Fox News contributor Julie Roginsky on the Pfizer-Allergan deal, corporate taxes in the U.S. and the top issues in the 2016 presidential race.
Watch Liz Claman talk about Elections on Closing Bell.
- published: 23 Nov 2015
- views: 26
Clinton, Sanders bash mega merger between Pfizer, Allergan
Say taxpayers will be left holding the bag
Watch Gary B Smith and Neil Cavuto talk about Democrats, Elections, Finance, Presidential Primaries, and Taxes on You...
Say taxpayers will be left holding the bag
Watch Gary B Smith and Neil Cavuto talk about Democrats, Elections, Finance, Presidential Primaries, and Taxes on Your World.
wn.com/Clinton, Sanders Bash Mega Merger Between Pfizer, Allergan
Say taxpayers will be left holding the bag
Watch Gary B Smith and Neil Cavuto talk about Democrats, Elections, Finance, Presidential Primaries, and Taxes on Your World.
- published: 23 Nov 2015
- views: 885
How Pfizer Is Going To Rob You
Pharmaceutical giant Pfizer is planning on merging with a counterpart in Ireland called Allergan. Critics are pointing out that if this merger is successful, it...
Pharmaceutical giant Pfizer is planning on merging with a counterpart in Ireland called Allergan. Critics are pointing out that if this merger is successful, it could save Pfizer a lot in taxes. Corporations like to base their company in Ireland because of their low corporate tax rate. The merger could cost American tax payers millions. Cenk Uygur and Ana Kasparian (The Point) hosts of The Young Turks discuss.
Should the government stop this merger? Will they? Let us know in the comments below.
Read more here: http://gawker.com/pfizer-and-allergan-will-team-up-to-paralyze-your-face-1744109654
“At the intersection of runaway corporate greed, the cold-blooded profiteering of pharmaceutical companies, and the generations-old, self-inflicted, crippling regulatory impotence of the U.S. government, the pending inversion of Phizer is dancing a little jig in a leprechaun costume and taking a steaming dump on the American flag.
So, inversions. Say a big U.S. corporation has already used up all the other tricks for avoiding paying taxes to our government. Here’s another neato trick they can pull: they can “merge” with a foreign-owned company—even a much smaller company—and, because they have been absorbed into this other company, they can now be headquartered wherever that other company calls home. Now, because they are no longer an American company, they pay corporate taxes to their new home country, where the corporate tax rate is substantially lower.
Voila! Just like that, an American company gets out of paying corporate taxes in America, because rinky-dink Sven’s Totally Not Fake Company LLC came on board. Sorry, Americans! It can’t be helped!”
***
Get The Young Turks Mobile App Today!
Download the iOS version here: https://itunes.apple.com/us/app/the-young-turks/id412793195?ls=1&mt;=8
Download the Android version here: https://play.google.com/store/apps/details?id=com.tyt
wn.com/How Pfizer Is Going To Rob You
Pharmaceutical giant Pfizer is planning on merging with a counterpart in Ireland called Allergan. Critics are pointing out that if this merger is successful, it could save Pfizer a lot in taxes. Corporations like to base their company in Ireland because of their low corporate tax rate. The merger could cost American tax payers millions. Cenk Uygur and Ana Kasparian (The Point) hosts of The Young Turks discuss.
Should the government stop this merger? Will they? Let us know in the comments below.
Read more here: http://gawker.com/pfizer-and-allergan-will-team-up-to-paralyze-your-face-1744109654
“At the intersection of runaway corporate greed, the cold-blooded profiteering of pharmaceutical companies, and the generations-old, self-inflicted, crippling regulatory impotence of the U.S. government, the pending inversion of Phizer is dancing a little jig in a leprechaun costume and taking a steaming dump on the American flag.
So, inversions. Say a big U.S. corporation has already used up all the other tricks for avoiding paying taxes to our government. Here’s another neato trick they can pull: they can “merge” with a foreign-owned company—even a much smaller company—and, because they have been absorbed into this other company, they can now be headquartered wherever that other company calls home. Now, because they are no longer an American company, they pay corporate taxes to their new home country, where the corporate tax rate is substantially lower.
Voila! Just like that, an American company gets out of paying corporate taxes in America, because rinky-dink Sven’s Totally Not Fake Company LLC came on board. Sorry, Americans! It can’t be helped!”
***
Get The Young Turks Mobile App Today!
Download the iOS version here: https://itunes.apple.com/us/app/the-young-turks/id412793195?ls=1&mt;=8
Download the Android version here: https://play.google.com/store/apps/details?id=com.tyt
- published: 28 Nov 2015
- views: 38651
Inside Pfizer, Allergan's Record $160B Deal
Nov. 23 -- Pfizer Inc. and Allergan Plc said they would combine operations in a stock transaction worth about $160 billion, creating a drugmaking behemoth with ...
Nov. 23 -- Pfizer Inc. and Allergan Plc said they would combine operations in a stock transaction worth about $160 billion, creating a drugmaking behemoth with products from Viagra to Botox and a low-cost tax base. Jefferies Chief Market Strategist David Zervos and Bloomberg's Cynthia Koons speak on "Bloomberg ‹GO›."
wn.com/Inside Pfizer, Allergan's Record 160B Deal
Nov. 23 -- Pfizer Inc. and Allergan Plc said they would combine operations in a stock transaction worth about $160 billion, creating a drugmaking behemoth with products from Viagra to Botox and a low-cost tax base. Jefferies Chief Market Strategist David Zervos and Bloomberg's Cynthia Koons speak on "Bloomberg ‹GO›."
- published: 23 Nov 2015
- views: 96
Pfizer to buy Allergan in $160bn deal
The US drug giant Pfizer, has sealed a deal to buy European-based group Allergan.
The one hundred and sixty billion dollar deal will be the largest pharmaceuti...
The US drug giant Pfizer, has sealed a deal to buy European-based group Allergan.
The one hundred and sixty billion dollar deal will be the largest pharmaceutical takeover in history.
It will allow Pfizer to move its headquarters to Ireland to escape high US corporate taxes.
Al Jazeera's Alan Fisher reports on how the move has been criticised by some.
Subscribe to our channel http://bit.ly/AJSubscribe
Follow us on Twitter https://twitter.com/AJEnglish
Find us on Facebook https://www.facebook.com/aljazeera
Check our website http://www.aljazeera.com/
wn.com/Pfizer To Buy Allergan In 160Bn Deal
The US drug giant Pfizer, has sealed a deal to buy European-based group Allergan.
The one hundred and sixty billion dollar deal will be the largest pharmaceutical takeover in history.
It will allow Pfizer to move its headquarters to Ireland to escape high US corporate taxes.
Al Jazeera's Alan Fisher reports on how the move has been criticised by some.
Subscribe to our channel http://bit.ly/AJSubscribe
Follow us on Twitter https://twitter.com/AJEnglish
Find us on Facebook https://www.facebook.com/aljazeera
Check our website http://www.aljazeera.com/
- published: 24 Nov 2015
- views: 246
Pfizer's Read on How Tax Code Harms Company
Pfizer CEO Ian Read explains how the pharmaceutical company is at a competitive disadvantage as a consequence of the U.S. tax code at the WSJ Viewpoints Executi...
Pfizer CEO Ian Read explains how the pharmaceutical company is at a competitive disadvantage as a consequence of the U.S. tax code at the WSJ Viewpoints Executive Breakfast Series.
Subscribe to the WSJ channel here:
http://bit.ly/14Q81Xy
More from the Wall Street Journal:
Visit WSJ.com: http://www.wsj.com
Follow WSJ on Facebook: http://www.facebook.com/wsjvideo
Follow WSJ on Google+: https://plus.google.com/+wsj/posts
Follow WSJ on Twitter: https://twitter.com/WSJvideo
Follow WSJ on Instagram: http://instagram.com/wsj
Follow WSJ on Pinterest: http://www.pinterest.com/wsj/
wn.com/Pfizer's Read On How Tax Code Harms Company
Pfizer CEO Ian Read explains how the pharmaceutical company is at a competitive disadvantage as a consequence of the U.S. tax code at the WSJ Viewpoints Executive Breakfast Series.
Subscribe to the WSJ channel here:
http://bit.ly/14Q81Xy
More from the Wall Street Journal:
Visit WSJ.com: http://www.wsj.com
Follow WSJ on Facebook: http://www.facebook.com/wsjvideo
Follow WSJ on Google+: https://plus.google.com/+wsj/posts
Follow WSJ on Twitter: https://twitter.com/WSJvideo
Follow WSJ on Instagram: http://instagram.com/wsj
Follow WSJ on Pinterest: http://www.pinterest.com/wsj/
- published: 29 Oct 2015
- views: 74
Q. Why do you work at Pfizer?
Laurie Olson, head of Pfizer’s Strategy, Portfolio, and Commercial Operations group, talks Laurie Olson, EVP Strategy and Portfolio, talks about why she works a...
Laurie Olson, head of Pfizer’s Strategy, Portfolio, and Commercial Operations group, talks Laurie Olson, EVP Strategy and Portfolio, talks about why she works at Pfizer and what inspires her to come to work every day.
wn.com/Q. Why Do You Work At Pfizer
Laurie Olson, head of Pfizer’s Strategy, Portfolio, and Commercial Operations group, talks Laurie Olson, EVP Strategy and Portfolio, talks about why she works at Pfizer and what inspires her to come to work every day.
- published: 17 Apr 2015
- views: 1250
Pfizer CEO on Potential for a Spinoff
At the WSJ Viewpoints Executive Breakfast Series, Pfizer CEO Ian Read discusses the potential for the company to spin off a portion of its business.
Subscribe ...
At the WSJ Viewpoints Executive Breakfast Series, Pfizer CEO Ian Read discusses the potential for the company to spin off a portion of its business.
Subscribe to the WSJ channel here:
http://bit.ly/14Q81Xy
More from the Wall Street Journal:
Visit WSJ.com: http://www.wsj.com
Follow WSJ on Facebook: http://www.facebook.com/wsjvideo
Follow WSJ on Google+: https://plus.google.com/+wsj/posts
Follow WSJ on Twitter: https://twitter.com/WSJvideo
Follow WSJ on Instagram: http://instagram.com/wsj
Follow WSJ on Pinterest: http://www.pinterest.com/wsj/
wn.com/Pfizer Ceo On Potential For A Spinoff
At the WSJ Viewpoints Executive Breakfast Series, Pfizer CEO Ian Read discusses the potential for the company to spin off a portion of its business.
Subscribe to the WSJ channel here:
http://bit.ly/14Q81Xy
More from the Wall Street Journal:
Visit WSJ.com: http://www.wsj.com
Follow WSJ on Facebook: http://www.facebook.com/wsjvideo
Follow WSJ on Google+: https://plus.google.com/+wsj/posts
Follow WSJ on Twitter: https://twitter.com/WSJvideo
Follow WSJ on Instagram: http://instagram.com/wsj
Follow WSJ on Pinterest: http://www.pinterest.com/wsj/
- published: 29 Oct 2015
- views: 135
Pfizer -- Largest Pharmaceutical Company In The World
The New York-based giant is one of the largest pharmaceutical companies in the world, based on revenues. Known for famous drugs like Lipitor and Viagra, Pfiz......
The New York-based giant is one of the largest pharmaceutical companies in the world, based on revenues. Known for famous drugs like Lipitor and Viagra, Pfiz...
wn.com/Pfizer Largest Pharmaceutical Company In The World
The New York-based giant is one of the largest pharmaceutical companies in the world, based on revenues. Known for famous drugs like Lipitor and Viagra, Pfiz...
Pfizer Corporate VDO
http://www.going2mars.com http://www.facebook.com/go2mars....
http://www.going2mars.com http://www.facebook.com/go2mars.
wn.com/Pfizer Corporate Vdo
http://www.going2mars.com http://www.facebook.com/go2mars.
Will regulators try to block the Pfizer-Allergan deal?
JPMorgan Global Head of Equity Strategy Steven Rees on Pfizer and Allergan reaching a deal to merge.
Watch Dagen Mcdowell and Maria Bartiromo talk about Investi...
JPMorgan Global Head of Equity Strategy Steven Rees on Pfizer and Allergan reaching a deal to merge.
Watch Dagen Mcdowell and Maria Bartiromo talk about Investing Basics on Mornings With Maria.
wn.com/Will Regulators Try To Block The Pfizer Allergan Deal
JPMorgan Global Head of Equity Strategy Steven Rees on Pfizer and Allergan reaching a deal to merge.
Watch Dagen Mcdowell and Maria Bartiromo talk about Investing Basics on Mornings With Maria.
- published: 23 Nov 2015
- views: 153
Graffiti - Pfizer commercial
There is more than a medication!...
There is more than a medication!
wn.com/Graffiti Pfizer Commercial
There is more than a medication!
- published: 21 Sep 2008
- views: 157245
-
author: Cyrus0933
Pfizer, Allergan Lead In Busy Year for Mergers
Drug makers Pfizer and Allergan have confirmed they are in talks for a possible merger, in what could be the latest deal in year marked by major mergers and acq...
Drug makers Pfizer and Allergan have confirmed they are in talks for a possible merger, in what could be the latest deal in year marked by major mergers and acquisitions. Photo: AP
Subscribe to the WSJ channel here:
http://bit.ly/14Q81Xy
More from the Wall Street Journal:
Visit WSJ.com: http://www.wsj.com
Follow WSJ on Facebook: http://www.facebook.com/wsjvideo
Follow WSJ on Google+: https://plus.google.com/+wsj/posts
Follow WSJ on Twitter: https://twitter.com/WSJvideo
Follow WSJ on Instagram: http://instagram.com/wsj
Follow WSJ on Pinterest: http://www.pinterest.com/wsj/
wn.com/Pfizer, Allergan Lead In Busy Year For Mergers
Drug makers Pfizer and Allergan have confirmed they are in talks for a possible merger, in what could be the latest deal in year marked by major mergers and acquisitions. Photo: AP
Subscribe to the WSJ channel here:
http://bit.ly/14Q81Xy
More from the Wall Street Journal:
Visit WSJ.com: http://www.wsj.com
Follow WSJ on Facebook: http://www.facebook.com/wsjvideo
Follow WSJ on Google+: https://plus.google.com/+wsj/posts
Follow WSJ on Twitter: https://twitter.com/WSJvideo
Follow WSJ on Instagram: http://instagram.com/wsj
Follow WSJ on Pinterest: http://www.pinterest.com/wsj/
- published: 30 Oct 2015
- views: 853
Behind Pfizer’s takeover of Allergan | Lex
► Subscribe to the Financial Times on YouTube: http://bit.ly/FTimeSubs
Pfizer on Monday announced the biggest healthcare deal in history by agreeing to acquire...
► Subscribe to the Financial Times on YouTube: http://bit.ly/FTimeSubs
Pfizer on Monday announced the biggest healthcare deal in history by agreeing to acquire Dublin-based Allergan. Lex’s Oliver Ralph and Robert Armstrong discuss what this deal entails for Pfizer and why its shares have not gone up yet.
For more video content from the Financial Times, visit http://www.FT.com/video
Twitter https://twitter.com/ftvideo
Facebook https://www.facebook.com/financialtimes
wn.com/Behind Pfizer’S Takeover Of Allergan | Lex
► Subscribe to the Financial Times on YouTube: http://bit.ly/FTimeSubs
Pfizer on Monday announced the biggest healthcare deal in history by agreeing to acquire Dublin-based Allergan. Lex’s Oliver Ralph and Robert Armstrong discuss what this deal entails for Pfizer and why its shares have not gone up yet.
For more video content from the Financial Times, visit http://www.FT.com/video
Twitter https://twitter.com/ftvideo
Facebook https://www.facebook.com/financialtimes
- published: 23 Nov 2015
- views: 84
Pfizer-Allergan $160 billion merger sparks debate
U.S. pharmaceutical giant Pfizer is buying Botox maker Allergan for 160 billion dollars. But size isn't everything. The deal involves Pfizer shifting its headqu...
U.S. pharmaceutical giant Pfizer is buying Botox maker Allergan for 160 billion dollars. But size isn't everything. The deal involves Pfizer shifting its headquarters to Ireland and that means it can slash its tax bill.
It has stoked a very contentious debate here in the U.S. and looks set to be a big issue in the presidential election. CCTV America's Shraysi Tandon reports.
wn.com/Pfizer Allergan 160 Billion Merger Sparks Debate
U.S. pharmaceutical giant Pfizer is buying Botox maker Allergan for 160 billion dollars. But size isn't everything. The deal involves Pfizer shifting its headquarters to Ireland and that means it can slash its tax bill.
It has stoked a very contentious debate here in the U.S. and looks set to be a big issue in the presidential election. CCTV America's Shraysi Tandon reports.
- published: 25 Nov 2015
- views: 37
Pfizer Tour
Portage and Kalamazoo government officials tour Pfizer's production facility, Building 41, in Portage Michigan. Video by Mark Bugnaski - Kalamazoo Gazette - ......
Portage and Kalamazoo government officials tour Pfizer's production facility, Building 41, in Portage Michigan. Video by Mark Bugnaski - Kalamazoo Gazette - ...
wn.com/Pfizer Tour
Portage and Kalamazoo government officials tour Pfizer's production facility, Building 41, in Portage Michigan. Video by Mark Bugnaski - Kalamazoo Gazette - ...
Our Immune System - Pfizer - Cortical Studios / Glow Studio
"Our Immune System," is an award-winning movie commissioned by Pfizer BV, that shows the complexity of inflammation and autoimmune diseases. In a joint effor......
"Our Immune System," is an award-winning movie commissioned by Pfizer BV, that shows the complexity of inflammation and autoimmune diseases. In a joint effor...
wn.com/Our Immune System Pfizer Cortical Studios Glow Studio
"Our Immune System," is an award-winning movie commissioned by Pfizer BV, that shows the complexity of inflammation and autoimmune diseases. In a joint effor...
Botox, Viagra or Placebo?: The Pfizer Allergan Deal
Pfizer is planning to buy Allergan in a mega-deal, motivated by two factors: the desire to buy growth (which it sorely lacks) and move out of US tax jurisdictio...
Pfizer is planning to buy Allergan in a mega-deal, motivated by two factors: the desire to buy growth (which it sorely lacks) and move out of US tax jurisdiction. In this webcast, I look at both but spend most of my time assessing the value effect of the tax code
Slides: http://www.stern.nyu.edu/~adamodar/pdfiles/blog/PfizerDeal.pdf
Spreadsheet: http://www.stern.nyu.edu/~adamodar/pc/blog/PfizerInversion2015.xls
Blog Post: http://aswathdamodaran.blogspot.com/2015/11/value-and-taxes-breaking-down-pfizer.html
wn.com/Botox, Viagra Or Placebo The Pfizer Allergan Deal
Pfizer is planning to buy Allergan in a mega-deal, motivated by two factors: the desire to buy growth (which it sorely lacks) and move out of US tax jurisdiction. In this webcast, I look at both but spend most of my time assessing the value effect of the tax code
Slides: http://www.stern.nyu.edu/~adamodar/pdfiles/blog/PfizerDeal.pdf
Spreadsheet: http://www.stern.nyu.edu/~adamodar/pc/blog/PfizerInversion2015.xls
Blog Post: http://aswathdamodaran.blogspot.com/2015/11/value-and-taxes-breaking-down-pfizer.html
- published: 18 Nov 2015
- views: 722
Protecting Viagra: Inside Pfizer's Fake Drug Lab
April 8 (Bloomberg) -- Boric acid, lead paint, sheet rock are just some of the ingredients found in counterfeit pills sold online. Bloomberg's Olivia Sterns ......
April 8 (Bloomberg) -- Boric acid, lead paint, sheet rock are just some of the ingredients found in counterfeit pills sold online. Bloomberg's Olivia Sterns ...
wn.com/Protecting Viagra Inside Pfizer's Fake Drug Lab
April 8 (Bloomberg) -- Boric acid, lead paint, sheet rock are just some of the ingredients found in counterfeit pills sold online. Bloomberg's Olivia Sterns ...
Pfizer: Lead by Example
President of Pfizer Consumer Healthcare, Paul Sturman, discusses his background and management style "At the Top"....
President of Pfizer Consumer Healthcare, Paul Sturman, discusses his background and management style "At the Top".
wn.com/Pfizer Lead By Example
President of Pfizer Consumer Healthcare, Paul Sturman, discusses his background and management style "At the Top".
- published: 31 Jul 2013
- views: 2399
-
author: CNN
Pfizer CEO testifies before UK parliamentary Panel
Bloomberg has the ownership of this material. It's posted here just for educational purposes. Is the french "idée" of democracy much more effective than in t......
Bloomberg has the ownership of this material. It's posted here just for educational purposes. Is the french "idée" of democracy much more effective than in t...
wn.com/Pfizer Ceo Testifies Before UK Parliamentary Panel
Bloomberg has the ownership of this material. It's posted here just for educational purposes. Is the french "idée" of democracy much more effective than in t...
- published: 13 May 2014
- views: 284
-
author: astienback
TEUTO Pfizer - Documentário Institucional
Cliente: Laboratório TEUTO Brasileiro
Agência: Agência A Propaganda
Material: Institucional
Atendimento: Vera Joy, José Veloso
Planejamento: Lucas Santos e Mar...
Cliente: Laboratório TEUTO Brasileiro
Agência: Agência A Propaganda
Material: Institucional
Atendimento: Vera Joy, José Veloso
Planejamento: Lucas Santos e Marisa Rodrigues
Mídia: Gláucia Sousa
Redação: Raoni Henrique e Francine Souza
Direção de Criação: Jonathas Veloso
Direção de Arte: Marcel Diego e Rafael Freitas
Web: Paulo Rosarf
Produtora: 30 Segundos Filmes
Direção do filme: Jonathas Veloso
Direção de Fotografia: Ronan Barcelos, Alexandre Rodrigues, Jonathas Veloso
Operador de Grua: Ronan Barcelos
Make up: Márcia Costa
Assistentes: Erick Eigidio, Israel Andrade e João Marcos
Produção executiva: Daiza Oliveira (TEUTO)
Edição: Jonathas Veloso
Direção Geral: José Veloso
wn.com/Teuto Pfizer Documentário Institucional
Cliente: Laboratório TEUTO Brasileiro
Agência: Agência A Propaganda
Material: Institucional
Atendimento: Vera Joy, José Veloso
Planejamento: Lucas Santos e Marisa Rodrigues
Mídia: Gláucia Sousa
Redação: Raoni Henrique e Francine Souza
Direção de Criação: Jonathas Veloso
Direção de Arte: Marcel Diego e Rafael Freitas
Web: Paulo Rosarf
Produtora: 30 Segundos Filmes
Direção do filme: Jonathas Veloso
Direção de Fotografia: Ronan Barcelos, Alexandre Rodrigues, Jonathas Veloso
Operador de Grua: Ronan Barcelos
Make up: Márcia Costa
Assistentes: Erick Eigidio, Israel Andrade e João Marcos
Produção executiva: Daiza Oliveira (TEUTO)
Edição: Jonathas Veloso
Direção Geral: José Veloso
- published: 24 Mar 2015
- views: 714
-
Pfizer: Health Care Innovation Best Practices
For more on the health industry, download the Novant Health case study here: https://www.spigit.com/novant-health/
As an enterprise leader, Pfizer talks about best practices on how to innovate to find unexpected ideas in a traditional industry such as healthcare. It is already a challenge to break through the existing infrastructure that enables the health care system to operate, including how ho
-
Pfizer and Watson playing Frisbee
-
Ian C Read-Pfizer
VIDEO FINANCIAL REPORTING
Why invest in is the first financial video platform where you can easily search through thousands of videos describing global securities.
About The Video:
The aim of this project is to offer an overview of CEO’s compensation of the biggest 500 US companies compared. In this video you can find data of salaries, bonus, restricted stock awards and total compensations. In or
-
Jonathan Cullen - Pfizer Canada Inc – Lexpert Rising Stars 2015
Click here for full biographical information: http://lexpert.ca/rising-stars/winner-detail/jonathan-cullen-pfizer-canada-inc-154
-
Allergan CEO Brent Saunders: Inside The Massive Deal With Pfizer | Mad Money | CNBC
It’s the company behind the biggest deal in the health care industry. What's next for Allergan? Jim Cramer finds out.
» Subscribe to CNBC: http://cnb.cx/SubscribeCNBC
» Watch more Mad Money here: http://bit.ly/WatchMadMoney
» Read more about Allergan here: http://cnb.cx/1Q9FAPp
"Mad Money" takes viewers inside the mind of one of Wall Street's most respected and successful money managers. Jim Crame
-
Pfizer-Allergan Merger: Is it Just About the US Taxes?
The Pfizer Allergan merger is the biggest Pharma merger ever and creates the largest healthcare company on the globe. But is this merger just about avoiding US taxes? Terry Chong, Global Healthcare Analyst, TD Asset Management discusses with MaryAnn.
-
Pfizer and Allergan announce US $160 billion merger deal - Kazakh TV
-
Wall St. opens little changed - Pfizer to buy Allergan.
Pfizer to buy Allergan in $160 billion (USD) deal. U.S. stocks open flat.
SHOWS:
NEW YORK, NEW YORK, UNITED STATES (NOVEMBER 23, 2015) (NYSE - ACCESS ALL)
1. OPENING BELL AT THE NEW YORK STOCK EXCHANGE (NYSE)
2. NYSE OPENING BOARD
3. NYSE FLOOR
NEW YORK, NEW YORK, UNITED STATES (NOVEMBER 23, 2015) (REUTERS - ACCESS ALL)
4. (SOUNDBITE) (English) STEPHEN WOOD, CHIEF MARKET STRATEGIST, RUSSELL
-
Hillary Clinton Accuses Pfizer Of Gaming Tax System | Calls To Prevent Inversions & Tax Dodge
US Presidential Candidate Hillary Clinton has accused Pfizer of gaming the tax system with its deal with Allergan, touted to be the largest deal of its kind. Hillary Clinton has called US Congress to whip such Inversions and Tax dodging deals.
For all top and best news stories happening all around you SUBSCRIBE to http://www.youtube.com/user/MangoNews?sub_confirmation=1
For all the news and lat
-
Pfizer et Allergan scellent la plus grosse fusion de l'année economy
Quand le Viagra épouse le Botox, cela donne une mégafusion de 160 milliards de dollars dans le secteur pharmaceutique, la plus grosse de l'année tous .
【引用元画像】 00:00:00.00 → ・Allergan - Leading Growth Pharma - Allergan 00:00:16.36 → ・AGN: Summary for Allergan plc Ordinary .
【引用元画像】 00:00:00.00 → ・Pfizer: One of the world's premier biopharmaceutical companies 00:00:16.36 → ・Pfizer - Wikip
-
DE Market Summary: Pfizer and Allergan
I created this video with the YouTube Video Editor (https://www.youtube.com/editor)
-
Pfizer Zithromax - Pfizer Brings To Letter Z For Zebra And The Curse Zithromax
https://www.hboasia.com/sesamestreet
Also YouTube Kids HBO Family
https://www.retrojunk.com/
-
Pfizer Life's Is Our Life's Work - You Always Different Ways To Keeps To Healthy (2000)
https://www.hboasia.com/sesamestreet
Also YouTube Kids & HBO Family
https://www.retrojunk.com/
-
Pfizer Life Is Our Life's Work - Through For 150 Years Pfizer We Health Commuted For Kids (1999)
https://www.hboasia.com/sesamestreet
Also Youtube Kids, HBO Family
https://www.retrojunk.com/
-
Fusion de Pfizer y Allergan, Alimentacion Organica y El nuevo virus de android indestructible
El nuevo virus de android indestructible
union pfizer y allegan
fusion pfizer y allergan
Fabricantes de Viagra y Botox se unen para pagar menos impuestos
Pfizer dueña de Viagra se fusionó este lunes con la irlandesa Allergan creadora de Botox
Alimentos orgánicos, una sana opción para los niños
Tres nuevos virus infectan más de 20.000 aplicaciones en Android
Un nuevo Adware que se adhiere a aplicac
-
Pfizer compra Allergan em operação de US$ 160 bilhões
Em entrevista ao programa Jovem Pan News, o presidente executivo do Sindusfarma, Nelson Mussolini, falou sobre a fusão entre as empresas e os benefícios que podem trazer à indústria farmacêutica, como estimular a inovação, pesquisa e desenvolvimento no setor.
-
Is America Powerless to Stop Pfizer Merger ?
Further videos about topics addressed are available in Recent Activities, Favorites, Play Lists on my channels. Mirrored and published with the permission of: https://www.youtube.com/user/TheRealNews
-
Hillary Clinton: Pfizer is gaming the tax system
Democratic presidential candidate Hillary Clinton has condemned Pfizer’s deal with Allergan, the largest ever of its kind, as a tax dodge on Tuesday. The frontrunner for the Democratic presidential nomination in the November 2016 election said she will propose steps to prevent more ‘inversions’ should she become president
-
Pfizer to buy Allergan in $160B deal - FoxTV Business News
Pfizer to buy Allergan in $160B deal - FoxTV Business News
Claman on Call: FBN’s Liz Claman with an after-hours web exclusive on the markets, Chipotle, the Pfizer-Allergan deal and gold prices.
-
Hillary Clinton says Pfizer 'gaming the tax system' condemns Pfizer's deal with Allergan- LoneWolf
Democratic presidential candidate Hillary Clinton condemns Pfizer's deal with Allergan as a tax dodge. - LoneWolf & The Three Muskadoggies(◑_◑)
"Please....Remember Our Homeless. Hospitalized & Disabled Veterans And Fallen Heroes! Thank You...America!" LoneWolf & The Three Muskadoggies
https://www.facebook.com/Whitehouseblog
TODAY...The WhiteHouse
TOMORROW....The United Nations!
What A "CAPITOL
-
Pfizer and Allergan Inversion Deal Explained
The $160 billion merger between Pfizer and Allergan highlights the continued trend in corporate inversion, a tactic used by US firms to avoid paying corporate taxes, and it’s completely legal. The deal is structured as a foreign acquisition where Allergen, a smaller and foreign firm is the buyer, taking advantage of Ireland’s low corporate tax rate. Pfizer claims the merger wasn’t only to lower ta
Pfizer: Health Care Innovation Best Practices
For more on the health industry, download the Novant Health case study here: https://www.spigit.com/novant-health/
As an enterprise leader, Pfizer talks about ...
For more on the health industry, download the Novant Health case study here: https://www.spigit.com/novant-health/
As an enterprise leader, Pfizer talks about best practices on how to innovate to find unexpected ideas in a traditional industry such as healthcare. It is already a challenge to break through the existing infrastructure that enables the health care system to operate, including how hospitals are set up to the way doctor visits are conducted. Pfizer was able to break through this barrier, as Wendy Mayer, VP of Worldwide Innovation, discusses best practices for:
- employee engagement
- customer engagement
- generating ideas
- measure near term and long term impact
- managing the idea pipeline
- surfacing unexpected ideas
- developing a culture where innovation is the norm
We all know the innovation landscape is changing fast, and enterprise leaders that go where their peers don’t normally go will achieve winning results. Capture inspiration and innovative ideas from your employees with Pfizer’s best practices today.
wn.com/Pfizer Health Care Innovation Best Practices
For more on the health industry, download the Novant Health case study here: https://www.spigit.com/novant-health/
As an enterprise leader, Pfizer talks about best practices on how to innovate to find unexpected ideas in a traditional industry such as healthcare. It is already a challenge to break through the existing infrastructure that enables the health care system to operate, including how hospitals are set up to the way doctor visits are conducted. Pfizer was able to break through this barrier, as Wendy Mayer, VP of Worldwide Innovation, discusses best practices for:
- employee engagement
- customer engagement
- generating ideas
- measure near term and long term impact
- managing the idea pipeline
- surfacing unexpected ideas
- developing a culture where innovation is the norm
We all know the innovation landscape is changing fast, and enterprise leaders that go where their peers don’t normally go will achieve winning results. Capture inspiration and innovative ideas from your employees with Pfizer’s best practices today.
- published: 02 Dec 2015
- views: 60
Ian C Read-Pfizer
VIDEO FINANCIAL REPORTING
Why invest in is the first financial video platform where you can easily search through thousands of videos describing global securit...
VIDEO FINANCIAL REPORTING
Why invest in is the first financial video platform where you can easily search through thousands of videos describing global securities.
About The Video:
The aim of this project is to offer an overview of CEO’s compensation of the biggest 500 US companies compared. In this video you can find data of salaries, bonus, restricted stock awards and total compensations. In order to offer a complete view of the situation, we COMPARE HISTORICAL STOCK PERFORMANCE WITH TOTAL CEO’s COMPENSATION CHANGE.
For this project, any kind of suggestion or critic will be helpful in order to develop and provide the best service as we can. Please visit our site www.whyinvestin.com and leave a massage to us.
Thank you and hope you will enjoy.
IMPORTANT INFORMATION - DISCLAIMER
THIS VIDEO IS FOR INFORMATION PURPOSES ONLY AND SHOULD NOT BE RELIED UPON AS INVESTMENT ADVICE. This video has been prepared by Whyinvestin (together with its affiliates, “Whyinvestin”) and is not intended to be taken by, and should not be taken by, any individual recipient as investment advice, a recommendation to buy, hold or sell any security, or an offer to sell or a solicitation of offers to purchase any security.
PAST PERFORMANCE IS NOT INDICATIVE OF FUTURE RESULTS. The performance of the companies discussed on this video is not necessarily indicative of the future performances.
Investors should consider the content of this video in conjunction with investment reports, financial statements and other disclosures regarding the valuations and performance of the specific companies discussed herein.
DO NOT RELY ON ANY OPINIONS, PREDICTIONS OR FORWARD-LOOKING STATEMENTS CONTAINED HEREIN. Certain of the information contained in this video constitutes “forward-looking statements” that are inherently unreliable and actual events or results may differ materially from those reflected or contemplated herein. None of Whyinvestin or any of its representatives makes any assurance as to the accuracy of those predictions or forward-looking statements. Whyinvestin expressly disclaims any obligation or undertaking to update or revise any such forward-looking statements.
EXTERNAL SOURCES. Certain information contained herein has been obtained from third-party sources. Although Whyinvestin believes such sources to be reliable, we make no representation as to its accuracy or completeness.
FINANCIAL DATA. Historical companies’ data, ratios, exchange rate, prices and estimates are provided by Factset research www.factset.com .
Whyinvestin does not verify any data and disclaims any obligation to do so. Whyinvestin, its data or content providers, the financial exchanges and each of their affiliates and business partners (A) expressly disclaim the accuracy, adequacy, or completeness of any data and (B) shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon. Neither Whyinvestin nor any of our information providers will be liable for any damages relating to your use of the information provided herein.
Please consult your broker or financial representative to verify pricing before executing any trade. Whyinvestin cannot guarantee the accuracy of the exchange rates used in the videos. You should confirm current rates before making any transactions that could be affected by changes in the exchange rates.
You agree not to copy, modify, reformat, download, store, reproduce, reprocess, transmit or redistribute any data or information found herein or use any such data or information in a commercial enterprise without obtaining prior written consent. Please consult your broker or financial representative to verify pricing before executing any trade.
COPYRIGHT “FAIR USE” Whyinvestin doesn’t own any logo different from the whyinvestin’ s logo contained in the video. The owner of the logos is the subject of the video itself (the company); and all the logos are not authorized by, sponsored by, or associated with the trademark owner .
Whyinvestin uses exclusive rights held by the copyright owner for Educational purposes and for commentary and criticism as part of a news report or published article.
If you are a company, subject of the video and for any reason want to get in contact with Whyinvestin please email:
company@whyinvestin.com
wn.com/Ian C Read Pfizer
VIDEO FINANCIAL REPORTING
Why invest in is the first financial video platform where you can easily search through thousands of videos describing global securities.
About The Video:
The aim of this project is to offer an overview of CEO’s compensation of the biggest 500 US companies compared. In this video you can find data of salaries, bonus, restricted stock awards and total compensations. In order to offer a complete view of the situation, we COMPARE HISTORICAL STOCK PERFORMANCE WITH TOTAL CEO’s COMPENSATION CHANGE.
For this project, any kind of suggestion or critic will be helpful in order to develop and provide the best service as we can. Please visit our site www.whyinvestin.com and leave a massage to us.
Thank you and hope you will enjoy.
IMPORTANT INFORMATION - DISCLAIMER
THIS VIDEO IS FOR INFORMATION PURPOSES ONLY AND SHOULD NOT BE RELIED UPON AS INVESTMENT ADVICE. This video has been prepared by Whyinvestin (together with its affiliates, “Whyinvestin”) and is not intended to be taken by, and should not be taken by, any individual recipient as investment advice, a recommendation to buy, hold or sell any security, or an offer to sell or a solicitation of offers to purchase any security.
PAST PERFORMANCE IS NOT INDICATIVE OF FUTURE RESULTS. The performance of the companies discussed on this video is not necessarily indicative of the future performances.
Investors should consider the content of this video in conjunction with investment reports, financial statements and other disclosures regarding the valuations and performance of the specific companies discussed herein.
DO NOT RELY ON ANY OPINIONS, PREDICTIONS OR FORWARD-LOOKING STATEMENTS CONTAINED HEREIN. Certain of the information contained in this video constitutes “forward-looking statements” that are inherently unreliable and actual events or results may differ materially from those reflected or contemplated herein. None of Whyinvestin or any of its representatives makes any assurance as to the accuracy of those predictions or forward-looking statements. Whyinvestin expressly disclaims any obligation or undertaking to update or revise any such forward-looking statements.
EXTERNAL SOURCES. Certain information contained herein has been obtained from third-party sources. Although Whyinvestin believes such sources to be reliable, we make no representation as to its accuracy or completeness.
FINANCIAL DATA. Historical companies’ data, ratios, exchange rate, prices and estimates are provided by Factset research www.factset.com .
Whyinvestin does not verify any data and disclaims any obligation to do so. Whyinvestin, its data or content providers, the financial exchanges and each of their affiliates and business partners (A) expressly disclaim the accuracy, adequacy, or completeness of any data and (B) shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon. Neither Whyinvestin nor any of our information providers will be liable for any damages relating to your use of the information provided herein.
Please consult your broker or financial representative to verify pricing before executing any trade. Whyinvestin cannot guarantee the accuracy of the exchange rates used in the videos. You should confirm current rates before making any transactions that could be affected by changes in the exchange rates.
You agree not to copy, modify, reformat, download, store, reproduce, reprocess, transmit or redistribute any data or information found herein or use any such data or information in a commercial enterprise without obtaining prior written consent. Please consult your broker or financial representative to verify pricing before executing any trade.
COPYRIGHT “FAIR USE” Whyinvestin doesn’t own any logo different from the whyinvestin’ s logo contained in the video. The owner of the logos is the subject of the video itself (the company); and all the logos are not authorized by, sponsored by, or associated with the trademark owner .
Whyinvestin uses exclusive rights held by the copyright owner for Educational purposes and for commentary and criticism as part of a news report or published article.
If you are a company, subject of the video and for any reason want to get in contact with Whyinvestin please email:
company@whyinvestin.com
- published: 01 Dec 2015
- views: 1
Jonathan Cullen - Pfizer Canada Inc – Lexpert Rising Stars 2015
Click here for full biographical information: http://lexpert.ca/rising-stars/winner-detail/jonathan-cullen-pfizer-canada-inc-154...
Click here for full biographical information: http://lexpert.ca/rising-stars/winner-detail/jonathan-cullen-pfizer-canada-inc-154
wn.com/Jonathan Cullen Pfizer Canada Inc – Lexpert Rising Stars 2015
Click here for full biographical information: http://lexpert.ca/rising-stars/winner-detail/jonathan-cullen-pfizer-canada-inc-154
- published: 01 Dec 2015
- views: 2
Allergan CEO Brent Saunders: Inside The Massive Deal With Pfizer | Mad Money | CNBC
It’s the company behind the biggest deal in the health care industry. What's next for Allergan? Jim Cramer finds out.
» Subscribe to CNBC: http://cnb.cx/Subscri...
It’s the company behind the biggest deal in the health care industry. What's next for Allergan? Jim Cramer finds out.
» Subscribe to CNBC: http://cnb.cx/SubscribeCNBC
» Watch more Mad Money here: http://bit.ly/WatchMadMoney
» Read more about Allergan here: http://cnb.cx/1Q9FAPp
"Mad Money" takes viewers inside the mind of one of Wall Street's most respected and successful money managers. Jim Cramer is your personal guide through the confusing jungle of Wall Street investing, navigating through both opportunities and pitfalls with one goal in mind -- to try to help you make money.
About CNBC: From 'Wall Street' to 'Main Street' to award winning original documentaries and Reality TV series, CNBC has you covered. Experience special sneak peeks of your favorite shows, exclusive video and more.
Get More Mad Money!
Read the latest news: http://madmoney.cnbc.com
Watch full episodes: http://bit.ly/MadMoneyEpisodes
Follow Mad Money on Twitter: http://bit.ly/MadMoneyTwitter
Like Mad Money on Facebook: http://bit.ly/LikeMadMoney
Follow Cramer on Twitter: http://bit.ly/FollowCramer
Connect with CNBC News Online!
Visit CNBC.com: http://www.cnbc.com/
Find CNBC News on Facebook: http://cnb.cx/LikeCNBC
Follow CNBC News on Twitter: http://cnb.cx/FollowCNBC
Follow CNBC News on Google+: http://cnb.cx/PlusCNBC
Follow CNBC News on Instagram: http://cnb.cx/InstagramCNBC
Allergan CEO Brent Saunders: Inside The Massive Deal With Pfizer | Mad Money | CNBC
wn.com/Allergan Ceo Brent Saunders Inside The Massive Deal With Pfizer | Mad Money | Cnbc
It’s the company behind the biggest deal in the health care industry. What's next for Allergan? Jim Cramer finds out.
» Subscribe to CNBC: http://cnb.cx/SubscribeCNBC
» Watch more Mad Money here: http://bit.ly/WatchMadMoney
» Read more about Allergan here: http://cnb.cx/1Q9FAPp
"Mad Money" takes viewers inside the mind of one of Wall Street's most respected and successful money managers. Jim Cramer is your personal guide through the confusing jungle of Wall Street investing, navigating through both opportunities and pitfalls with one goal in mind -- to try to help you make money.
About CNBC: From 'Wall Street' to 'Main Street' to award winning original documentaries and Reality TV series, CNBC has you covered. Experience special sneak peeks of your favorite shows, exclusive video and more.
Get More Mad Money!
Read the latest news: http://madmoney.cnbc.com
Watch full episodes: http://bit.ly/MadMoneyEpisodes
Follow Mad Money on Twitter: http://bit.ly/MadMoneyTwitter
Like Mad Money on Facebook: http://bit.ly/LikeMadMoney
Follow Cramer on Twitter: http://bit.ly/FollowCramer
Connect with CNBC News Online!
Visit CNBC.com: http://www.cnbc.com/
Find CNBC News on Facebook: http://cnb.cx/LikeCNBC
Follow CNBC News on Twitter: http://cnb.cx/FollowCNBC
Follow CNBC News on Google+: http://cnb.cx/PlusCNBC
Follow CNBC News on Instagram: http://cnb.cx/InstagramCNBC
Allergan CEO Brent Saunders: Inside The Massive Deal With Pfizer | Mad Money | CNBC
- published: 01 Dec 2015
- views: 163
Pfizer-Allergan Merger: Is it Just About the US Taxes?
The Pfizer Allergan merger is the biggest Pharma merger ever and creates the largest healthcare company on the globe. But is this merger just about avoiding US ...
The Pfizer Allergan merger is the biggest Pharma merger ever and creates the largest healthcare company on the globe. But is this merger just about avoiding US taxes? Terry Chong, Global Healthcare Analyst, TD Asset Management discusses with MaryAnn.
wn.com/Pfizer Allergan Merger Is It Just About The US Taxes
The Pfizer Allergan merger is the biggest Pharma merger ever and creates the largest healthcare company on the globe. But is this merger just about avoiding US taxes? Terry Chong, Global Healthcare Analyst, TD Asset Management discusses with MaryAnn.
- published: 30 Nov 2015
- views: 47
Wall St. opens little changed - Pfizer to buy Allergan.
Pfizer to buy Allergan in $160 billion (USD) deal. U.S. stocks open flat.
SHOWS:
NEW YORK, NEW YORK, UNITED STATES (NOVEMBER 23, 2015) (NYSE - ACCESS ALL)
1....
Pfizer to buy Allergan in $160 billion (USD) deal. U.S. stocks open flat.
SHOWS:
NEW YORK, NEW YORK, UNITED STATES (NOVEMBER 23, 2015) (NYSE - ACCESS ALL)
1. OPENING BELL AT THE NEW YORK STOCK EXCHANGE (NYSE)
2. NYSE OPENING BOARD
3. NYSE FLOOR
NEW YORK, NEW YORK, UNITED STATES (NOVEMBER 23, 2015) (REUTERS - ACCESS ALL)
4. (SOUNDBITE) (English) STEPHEN WOOD, CHIEF MARKET STRATEGIST, RUSSELL INVESTMENTS
"If one looks at the tax structure in the United States versus other OECD (Organisation for Economic Co-operation and Development) countries, there's a spread. There's a differential. So inversions, a lot of these deals may be more a function of regulatory and tax policy then they maybe of anything else. So one would expect that as long as there are these regulatory arbitrage opportunities, the companies will explore them."
NEW YORK, NEW YORK, UNITED STATES (FILE) (PFIZER HANDOUT - ACCESS ALL) (PART MUTE)
5. VARIOUS OF EXTERIORS OF PFIZER HEADQUARTERS
DUBLIN, IRELAND (FILE) (REUTERS - ACCESS ALL) (MUTE)
6. PHOTOGRAPH OF PFIZER OFFICE IN DUBLIN
INTERNET (FILE) (REUTERS - ACCESS ALL) (MUTE)
7. ALLERGAN WEBSITE
UNIDENTIFIED LOCATION (FILE) (PFIZER HANDOUT - ACCESS ALL) (MUTE)
8. VARIOUS OF LABORATORY
STORY: U.S. stocks opened little changed on Monday (November 23), coming off last week's strong gains, as gains in consumer staples offset losses in energy stocks.
The Dow Jones industrial average rose 2.14 points, or 0.01 percent, to 17,825.95. The S&P; 500 gained 0.2 points, or 0.01 percent, to 2,089.37 and the Nasdaq Composite index added 1.11 points, or 0.02 percent, to 5,106.03.
Also, Pfizer Inc on Monday said it would buy Botox maker Allergan Plc in a record-breaking deal worth $160 billion (USD), designed to cut the company's U.S. tax bill by moving its headquarters to Ireland.
The merger, which will create the world's largest drugmaker, will delay the Lipitor and Viagra maker's decision on whether to split by two years to late 2018, Pfizer said.
Investors had been hoping Pfizer would sell off its low-margin generics by 2017 while holding on to its faster-growing branded prescription drugs, a move that will be delayed by the time required to integrate Allergan.
While the deal is structured as Allergan buying Pfizer, Pfizer would retain control of the company.
The tax aspect of the deal has been seen as critical. The U.S. corporate tax rate of 35 percent is among the world's highest, while Ireland's is just 12.5 percent.
"If one looks at the tax structure in the United States versus other OECD (Organisation for Economic Co-operation and Development) countries, there's a spread. There's a differential. So inversions, a lot of these deals may be more a function of regulatory and tax policy then they maybe of anything else. So one would expect that as long as there are these regulatory arbitrage opportunities, the companies will explore them," said Stephen Wood, chief market strategist at Russell Investments.
Pfizer Chief Executive Officer Ian Read will hold that position at the combined entity, while Allergan CEO Brent Saunders will be president and chief operating officer.
The deal values Allergan's shares at $363.63 each, about 16 percent more than their closing price of $312.46 on Friday.
Allergan shareholders would receive 11.3 shares in the combined company for each of their shares.
wn.com/Wall St. Opens Little Changed Pfizer To Buy Allergan.
Pfizer to buy Allergan in $160 billion (USD) deal. U.S. stocks open flat.
SHOWS:
NEW YORK, NEW YORK, UNITED STATES (NOVEMBER 23, 2015) (NYSE - ACCESS ALL)
1. OPENING BELL AT THE NEW YORK STOCK EXCHANGE (NYSE)
2. NYSE OPENING BOARD
3. NYSE FLOOR
NEW YORK, NEW YORK, UNITED STATES (NOVEMBER 23, 2015) (REUTERS - ACCESS ALL)
4. (SOUNDBITE) (English) STEPHEN WOOD, CHIEF MARKET STRATEGIST, RUSSELL INVESTMENTS
"If one looks at the tax structure in the United States versus other OECD (Organisation for Economic Co-operation and Development) countries, there's a spread. There's a differential. So inversions, a lot of these deals may be more a function of regulatory and tax policy then they maybe of anything else. So one would expect that as long as there are these regulatory arbitrage opportunities, the companies will explore them."
NEW YORK, NEW YORK, UNITED STATES (FILE) (PFIZER HANDOUT - ACCESS ALL) (PART MUTE)
5. VARIOUS OF EXTERIORS OF PFIZER HEADQUARTERS
DUBLIN, IRELAND (FILE) (REUTERS - ACCESS ALL) (MUTE)
6. PHOTOGRAPH OF PFIZER OFFICE IN DUBLIN
INTERNET (FILE) (REUTERS - ACCESS ALL) (MUTE)
7. ALLERGAN WEBSITE
UNIDENTIFIED LOCATION (FILE) (PFIZER HANDOUT - ACCESS ALL) (MUTE)
8. VARIOUS OF LABORATORY
STORY: U.S. stocks opened little changed on Monday (November 23), coming off last week's strong gains, as gains in consumer staples offset losses in energy stocks.
The Dow Jones industrial average rose 2.14 points, or 0.01 percent, to 17,825.95. The S&P; 500 gained 0.2 points, or 0.01 percent, to 2,089.37 and the Nasdaq Composite index added 1.11 points, or 0.02 percent, to 5,106.03.
Also, Pfizer Inc on Monday said it would buy Botox maker Allergan Plc in a record-breaking deal worth $160 billion (USD), designed to cut the company's U.S. tax bill by moving its headquarters to Ireland.
The merger, which will create the world's largest drugmaker, will delay the Lipitor and Viagra maker's decision on whether to split by two years to late 2018, Pfizer said.
Investors had been hoping Pfizer would sell off its low-margin generics by 2017 while holding on to its faster-growing branded prescription drugs, a move that will be delayed by the time required to integrate Allergan.
While the deal is structured as Allergan buying Pfizer, Pfizer would retain control of the company.
The tax aspect of the deal has been seen as critical. The U.S. corporate tax rate of 35 percent is among the world's highest, while Ireland's is just 12.5 percent.
"If one looks at the tax structure in the United States versus other OECD (Organisation for Economic Co-operation and Development) countries, there's a spread. There's a differential. So inversions, a lot of these deals may be more a function of regulatory and tax policy then they maybe of anything else. So one would expect that as long as there are these regulatory arbitrage opportunities, the companies will explore them," said Stephen Wood, chief market strategist at Russell Investments.
Pfizer Chief Executive Officer Ian Read will hold that position at the combined entity, while Allergan CEO Brent Saunders will be president and chief operating officer.
The deal values Allergan's shares at $363.63 each, about 16 percent more than their closing price of $312.46 on Friday.
Allergan shareholders would receive 11.3 shares in the combined company for each of their shares.
- published: 26 Nov 2015
- views: 6
Hillary Clinton Accuses Pfizer Of Gaming Tax System | Calls To Prevent Inversions & Tax Dodge
US Presidential Candidate Hillary Clinton has accused Pfizer of gaming the tax system with its deal with Allergan, touted to be the largest deal of its kind. Hi...
US Presidential Candidate Hillary Clinton has accused Pfizer of gaming the tax system with its deal with Allergan, touted to be the largest deal of its kind. Hillary Clinton has called US Congress to whip such Inversions and Tax dodging deals.
For all top and best news stories happening all around you SUBSCRIBE to http://www.youtube.com/user/MangoNews?sub_confirmation=1
For all the news and latest updates, like us @ https://www.facebook.com/MangoNews
Follow us on Twitter : http://www.twitter.com/Mango_News
Check us out on Google+ : https://plus.google.com/+mangonews
Visit us @ http://themangonews.com
wn.com/Hillary Clinton Accuses Pfizer Of Gaming Tax System | Calls To Prevent Inversions Tax Dodge
US Presidential Candidate Hillary Clinton has accused Pfizer of gaming the tax system with its deal with Allergan, touted to be the largest deal of its kind. Hillary Clinton has called US Congress to whip such Inversions and Tax dodging deals.
For all top and best news stories happening all around you SUBSCRIBE to http://www.youtube.com/user/MangoNews?sub_confirmation=1
For all the news and latest updates, like us @ https://www.facebook.com/MangoNews
Follow us on Twitter : http://www.twitter.com/Mango_News
Check us out on Google+ : https://plus.google.com/+mangonews
Visit us @ http://themangonews.com
- published: 26 Nov 2015
- views: 61
Pfizer et Allergan scellent la plus grosse fusion de l'année economy
Quand le Viagra épouse le Botox, cela donne une mégafusion de 160 milliards de dollars dans le secteur pharmaceutique, la plus grosse de l'année tous .
【引用元画...
Quand le Viagra épouse le Botox, cela donne une mégafusion de 160 milliards de dollars dans le secteur pharmaceutique, la plus grosse de l'année tous .
【引用元画像】 00:00:00.00 → ・Allergan - Leading Growth Pharma - Allergan 00:00:16.36 → ・AGN: Summary for Allergan plc Ordinary .
【引用元画像】 00:00:00.00 → ・Pfizer: One of the world's premier biopharmaceutical companies 00:00:16.36 → ・Pfizer - Wikipedia, the free .
wn.com/Pfizer Et Allergan Scellent La Plus Grosse Fusion De L'Année Economy
Quand le Viagra épouse le Botox, cela donne une mégafusion de 160 milliards de dollars dans le secteur pharmaceutique, la plus grosse de l'année tous .
【引用元画像】 00:00:00.00 → ・Allergan - Leading Growth Pharma - Allergan 00:00:16.36 → ・AGN: Summary for Allergan plc Ordinary .
【引用元画像】 00:00:00.00 → ・Pfizer: One of the world's premier biopharmaceutical companies 00:00:16.36 → ・Pfizer - Wikipedia, the free .
- published: 26 Nov 2015
- views: 1
DE Market Summary: Pfizer and Allergan
I created this video with the YouTube Video Editor (https://www.youtube.com/editor)...
I created this video with the YouTube Video Editor (https://www.youtube.com/editor)
wn.com/De Market Summary Pfizer And Allergan
I created this video with the YouTube Video Editor (https://www.youtube.com/editor)
- published: 26 Nov 2015
- views: 1
Pfizer Zithromax - Pfizer Brings To Letter Z For Zebra And The Curse Zithromax
https://www.hboasia.com/sesamestreet
Also YouTube Kids HBO Family
https://www.retrojunk.com/...
https://www.hboasia.com/sesamestreet
Also YouTube Kids HBO Family
https://www.retrojunk.com/
wn.com/Pfizer Zithromax Pfizer Brings To Letter Z For Zebra And The Curse Zithromax
https://www.hboasia.com/sesamestreet
Also YouTube Kids HBO Family
https://www.retrojunk.com/
- published: 26 Nov 2015
- views: 6
Pfizer Life's Is Our Life's Work - You Always Different Ways To Keeps To Healthy (2000)
https://www.hboasia.com/sesamestreet
Also YouTube Kids & HBO Family
https://www.retrojunk.com/...
https://www.hboasia.com/sesamestreet
Also YouTube Kids & HBO Family
https://www.retrojunk.com/
wn.com/Pfizer Life's Is Our Life's Work You Always Different Ways To Keeps To Healthy (2000)
https://www.hboasia.com/sesamestreet
Also YouTube Kids & HBO Family
https://www.retrojunk.com/
- published: 26 Nov 2015
- views: 6
Pfizer Life Is Our Life's Work - Through For 150 Years Pfizer We Health Commuted For Kids (1999)
https://www.hboasia.com/sesamestreet
Also Youtube Kids, HBO Family
https://www.retrojunk.com/...
https://www.hboasia.com/sesamestreet
Also Youtube Kids, HBO Family
https://www.retrojunk.com/
wn.com/Pfizer Life Is Our Life's Work Through For 150 Years Pfizer We Health Commuted For Kids (1999)
https://www.hboasia.com/sesamestreet
Also Youtube Kids, HBO Family
https://www.retrojunk.com/
- published: 26 Nov 2015
- views: 16
Fusion de Pfizer y Allergan, Alimentacion Organica y El nuevo virus de android indestructible
El nuevo virus de android indestructible
union pfizer y allegan
fusion pfizer y allergan
Fabricantes de Viagra y Botox se unen para pagar menos impuestos
Pfizer...
El nuevo virus de android indestructible
union pfizer y allegan
fusion pfizer y allergan
Fabricantes de Viagra y Botox se unen para pagar menos impuestos
Pfizer dueña de Viagra se fusionó este lunes con la irlandesa Allergan creadora de Botox
Alimentos orgánicos, una sana opción para los niños
Tres nuevos virus infectan más de 20.000 aplicaciones en Android
Un nuevo Adware que se adhiere a aplicaciones populares como Facebook y Twitter se ha vuelto imposible de eliminar
Los tres virus, Shedun, Shuanet y ShiftyBug
Si Te Gusto el Vídeo Danos Un Like Si NO Te Gusto Déjanos Una Critica Constructiva en los Comentarios..
▬▬▬▬▬▬▬▬▬▬▬ஜ۩۞۩ஜ▬▬▬▬▬▬▬▬▬▬▬▬▬▬
▓▓▓▒▒▒░░░ LEA LA DESCRIPCIÓN DEL VÍDEO ░░░▒▒▒▓▓▓
▬▬▬▬▬▬▬▬▬▬▬ஜ۩۞۩ஜ▬▬▬▬▬▬▬▬▬▬▬▬▬▬
▀▄▀▄▀▄▀▄▀▄▀▄▀▄▀▄▀▄▀▄▀▄▀▄
╔═╦╗╔╦═╦═╦╦╦╦╗╔═╦══╦═╗
║╚╣║║║╚╣╔╣╔╣║╚╣═╬╗╔╣═╣
╠╗║╚╝╠╗║╚╣║║║║║═╣║║║═╣
╚═╩══╩═╩═╩╝╚╩═╩═╝╚╝╚═╝
▀▄▀▄▀▄▀▄▀▄▀▄▀▄▀▄▀▄▀▄▀▄▀▄
▬▬▬▬▬▬▬▬▬▬▬ Redes Sociales ▬▬▬▬▬▬▬▬▬▬▬
► Mira Nuestros Vídeos Anteriores:
YOUTUBE:
https://www.youtube.com/channel/UCyJqB8_iCMjhLirivJnJHZQ
DAILYMOTION:
http://www.dailymotion.com/aeglt
TWITTER:
https://twitter.com/aeglt_2
FACEBOOK:
https://www.facebook.com/andres.guerra.3576
INSTAGRAM:
https://instagram.com/aeglt_2/
▬▬▬▬▬▬▬▬▬▬▬ஜ۩۞۩ஜ▬▬▬▬▬▬▬▬▬▬▬▬▬▬
Si Te Gusto el Vídeo Danos Un Like Si NO Te Gusto Déjanos Una Critica Constructiva en los Comentarios..
Copyright Disclaimer Under Section 107 of the Copyright Act 1976, allowance is made for "fair use" for purposes such as criticism, comment, news reporting, teaching, scholarship, and research. Fair use is a use permitted by copyright statute that might otherwise be infringing. Non-profit, educational or personal use tips the balance in favor of fair use
wn.com/Fusion De Pfizer Y Allergan, Alimentacion Organica Y El Nuevo Virus De Android Indestructible
El nuevo virus de android indestructible
union pfizer y allegan
fusion pfizer y allergan
Fabricantes de Viagra y Botox se unen para pagar menos impuestos
Pfizer dueña de Viagra se fusionó este lunes con la irlandesa Allergan creadora de Botox
Alimentos orgánicos, una sana opción para los niños
Tres nuevos virus infectan más de 20.000 aplicaciones en Android
Un nuevo Adware que se adhiere a aplicaciones populares como Facebook y Twitter se ha vuelto imposible de eliminar
Los tres virus, Shedun, Shuanet y ShiftyBug
Si Te Gusto el Vídeo Danos Un Like Si NO Te Gusto Déjanos Una Critica Constructiva en los Comentarios..
▬▬▬▬▬▬▬▬▬▬▬ஜ۩۞۩ஜ▬▬▬▬▬▬▬▬▬▬▬▬▬▬
▓▓▓▒▒▒░░░ LEA LA DESCRIPCIÓN DEL VÍDEO ░░░▒▒▒▓▓▓
▬▬▬▬▬▬▬▬▬▬▬ஜ۩۞۩ஜ▬▬▬▬▬▬▬▬▬▬▬▬▬▬
▀▄▀▄▀▄▀▄▀▄▀▄▀▄▀▄▀▄▀▄▀▄▀▄
╔═╦╗╔╦═╦═╦╦╦╦╗╔═╦══╦═╗
║╚╣║║║╚╣╔╣╔╣║╚╣═╬╗╔╣═╣
╠╗║╚╝╠╗║╚╣║║║║║═╣║║║═╣
╚═╩══╩═╩═╩╝╚╩═╩═╝╚╝╚═╝
▀▄▀▄▀▄▀▄▀▄▀▄▀▄▀▄▀▄▀▄▀▄▀▄
▬▬▬▬▬▬▬▬▬▬▬ Redes Sociales ▬▬▬▬▬▬▬▬▬▬▬
► Mira Nuestros Vídeos Anteriores:
YOUTUBE:
https://www.youtube.com/channel/UCyJqB8_iCMjhLirivJnJHZQ
DAILYMOTION:
http://www.dailymotion.com/aeglt
TWITTER:
https://twitter.com/aeglt_2
FACEBOOK:
https://www.facebook.com/andres.guerra.3576
INSTAGRAM:
https://instagram.com/aeglt_2/
▬▬▬▬▬▬▬▬▬▬▬ஜ۩۞۩ஜ▬▬▬▬▬▬▬▬▬▬▬▬▬▬
Si Te Gusto el Vídeo Danos Un Like Si NO Te Gusto Déjanos Una Critica Constructiva en los Comentarios..
Copyright Disclaimer Under Section 107 of the Copyright Act 1976, allowance is made for "fair use" for purposes such as criticism, comment, news reporting, teaching, scholarship, and research. Fair use is a use permitted by copyright statute that might otherwise be infringing. Non-profit, educational or personal use tips the balance in favor of fair use
- published: 25 Nov 2015
- views: 16
Pfizer compra Allergan em operação de US$ 160 bilhões
Em entrevista ao programa Jovem Pan News, o presidente executivo do Sindusfarma, Nelson Mussolini, falou sobre a fusão entre as empresas e os benefícios que pod...
Em entrevista ao programa Jovem Pan News, o presidente executivo do Sindusfarma, Nelson Mussolini, falou sobre a fusão entre as empresas e os benefícios que podem trazer à indústria farmacêutica, como estimular a inovação, pesquisa e desenvolvimento no setor.
wn.com/Pfizer Compra Allergan Em Operação De US 160 Bilhões
Em entrevista ao programa Jovem Pan News, o presidente executivo do Sindusfarma, Nelson Mussolini, falou sobre a fusão entre as empresas e os benefícios que podem trazer à indústria farmacêutica, como estimular a inovação, pesquisa e desenvolvimento no setor.
- published: 25 Nov 2015
- views: 2
Is America Powerless to Stop Pfizer Merger ?
Further videos about topics addressed are available in Recent Activities, Favorites, Play Lists on my channels. Mirrored and published with the permission of: h...
Further videos about topics addressed are available in Recent Activities, Favorites, Play Lists on my channels. Mirrored and published with the permission of: https://www.youtube.com/user/TheRealNews
wn.com/Is America Powerless To Stop Pfizer Merger
Further videos about topics addressed are available in Recent Activities, Favorites, Play Lists on my channels. Mirrored and published with the permission of: https://www.youtube.com/user/TheRealNews
- published: 25 Nov 2015
- views: 12
Hillary Clinton: Pfizer is gaming the tax system
Democratic presidential candidate Hillary Clinton has condemned Pfizer’s deal with Allergan, the largest ever of its kind, as a tax dodge on Tuesday. The frontr...
Democratic presidential candidate Hillary Clinton has condemned Pfizer’s deal with Allergan, the largest ever of its kind, as a tax dodge on Tuesday. The frontrunner for the Democratic presidential nomination in the November 2016 election said she will propose steps to prevent more ‘inversions’ should she become president
wn.com/Hillary Clinton Pfizer Is Gaming The Tax System
Democratic presidential candidate Hillary Clinton has condemned Pfizer’s deal with Allergan, the largest ever of its kind, as a tax dodge on Tuesday. The frontrunner for the Democratic presidential nomination in the November 2016 election said she will propose steps to prevent more ‘inversions’ should she become president
- published: 25 Nov 2015
- views: 21
Pfizer to buy Allergan in $160B deal - FoxTV Business News
Pfizer to buy Allergan in $160B deal - FoxTV Business News
Claman on Call: FBN’s Liz Claman with an after-hours web exclusive on the markets, Chipotle, the Pfi...
Pfizer to buy Allergan in $160B deal - FoxTV Business News
Claman on Call: FBN’s Liz Claman with an after-hours web exclusive on the markets, Chipotle, the Pfizer-Allergan deal and gold prices.
wn.com/Pfizer To Buy Allergan In 160B Deal Foxtv Business News
Pfizer to buy Allergan in $160B deal - FoxTV Business News
Claman on Call: FBN’s Liz Claman with an after-hours web exclusive on the markets, Chipotle, the Pfizer-Allergan deal and gold prices.
- published: 25 Nov 2015
- views: 15
Hillary Clinton says Pfizer 'gaming the tax system' condemns Pfizer's deal with Allergan- LoneWolf
Democratic presidential candidate Hillary Clinton condemns Pfizer's deal with Allergan as a tax dodge. - LoneWolf & The Three Muskadoggies(◑_◑)
"Please....Rem...
Democratic presidential candidate Hillary Clinton condemns Pfizer's deal with Allergan as a tax dodge. - LoneWolf & The Three Muskadoggies(◑_◑)
"Please....Remember Our Homeless. Hospitalized & Disabled Veterans And Fallen Heroes! Thank You...America!" LoneWolf & The Three Muskadoggies
https://www.facebook.com/Whitehouseblog
TODAY...The WhiteHouse
TOMORROW....The United Nations!
What A "CAPITOL" Idea!
"Watch Out(◑_◑) .......LoneWolf Is On The Loose!"
wn.com/Hillary Clinton Says Pfizer 'Gaming The Tax System' Condemns Pfizer's Deal With Allergan Lonewolf
Democratic presidential candidate Hillary Clinton condemns Pfizer's deal with Allergan as a tax dodge. - LoneWolf & The Three Muskadoggies(◑_◑)
"Please....Remember Our Homeless. Hospitalized & Disabled Veterans And Fallen Heroes! Thank You...America!" LoneWolf & The Three Muskadoggies
https://www.facebook.com/Whitehouseblog
TODAY...The WhiteHouse
TOMORROW....The United Nations!
What A "CAPITOL" Idea!
"Watch Out(◑_◑) .......LoneWolf Is On The Loose!"
- published: 24 Nov 2015
- views: 26
Pfizer and Allergan Inversion Deal Explained
The $160 billion merger between Pfizer and Allergan highlights the continued trend in corporate inversion, a tactic used by US firms to avoid paying corporate t...
The $160 billion merger between Pfizer and Allergan highlights the continued trend in corporate inversion, a tactic used by US firms to avoid paying corporate taxes, and it’s completely legal. The deal is structured as a foreign acquisition where Allergen, a smaller and foreign firm is the buyer, taking advantage of Ireland’s low corporate tax rate. Pfizer claims the merger wasn’t only to lower taxes but also to allow more “financial flexibility” to invest in research, development and manufacturing. The US Treasury Department is trying to make inversion more difficult by adding more restrictions and issuing technical rules limiting the ability of US companies to merge with foreign firms. Jose Marcelino Ortiz and Nik Zecevic further break down the merger and inversion tactic on The Lip News.
http://www.latimes.com/business/la-fi-pfizer-allergan-merger-20151123-story.html
http://thelip.tv/
http://www.youtube.com/theliptv2
wn.com/Pfizer And Allergan Inversion Deal Explained
The $160 billion merger between Pfizer and Allergan highlights the continued trend in corporate inversion, a tactic used by US firms to avoid paying corporate taxes, and it’s completely legal. The deal is structured as a foreign acquisition where Allergen, a smaller and foreign firm is the buyer, taking advantage of Ireland’s low corporate tax rate. Pfizer claims the merger wasn’t only to lower taxes but also to allow more “financial flexibility” to invest in research, development and manufacturing. The US Treasury Department is trying to make inversion more difficult by adding more restrictions and issuing technical rules limiting the ability of US companies to merge with foreign firms. Jose Marcelino Ortiz and Nik Zecevic further break down the merger and inversion tactic on The Lip News.
http://www.latimes.com/business/la-fi-pfizer-allergan-merger-20151123-story.html
http://thelip.tv/
http://www.youtube.com/theliptv2
- published: 24 Nov 2015
- views: 101
-
The Binding of Isaac: Rebirth - Let's Play - Episode 374 [Pfizer]
Seed: TPHE VKA0
Subscribe to my channel for more gaming videos!: http://bit.ly/Northernlion
If you enjoyed the video, please consider hitting the Like button. It helps me out a lot!
Follow me on Twitter: http://twitter.com/NorthernlionLP
Follow me on Facebook: http://facebook.com/Northernlion
As Northernlion, I produce a variety of gaming content for YouTube every single day. Be sure to tune
-
Dave Cagney - Pfizer Newbridge
Dave Cagney of Pfizer Newbridge speaks at the 2015 National Manufacturing and Supply Chain Conference & Exhibition.
http://www.prempub.com
-
Reimagine operations with analytics, technology and process innovation The Pfizer story
Reimagining processes requires a combination of domain expertise, operational prowess, a deep understanding of the desired business outcomes, and smart application of analytics and technology.
Mark Harf, Center of Excellence Lead for Pfizer’s Global Commercial Operations, and Paul Burton, SVP and Business Leader for Analytics at Genpact, are pioneering industry-leading practices in their organi
-
PF-06252616 (Anti-Myostatin) Webinar [June 2015]
On June 3, 2015, Dr. Michael Binks, Vice President for Rare Disease Clinical Research at Pfizer, presented information about the upcoming clinical trial of PF-06252616. The webinar provides an overview of Pfizer’s approach to advancing the science of an anti-myostatin monoclonal antibody as an investigational compound for potential therapeutic use in muscle wasting diseases, such as Duchenne musc
-
Designing Proof-of-Concept Clinical Trials - Ashwin Gollerkeri, M.D.
Innovations in statistics, programming and data management are changing the very nature of clinical development. Cytel thought-leaders reveal cutting-edge techniques that streamline and truly accelerate product developmental at the clinical trial, program and portfolio level.
Featuring, Simulation and biomarkers speeding development at Merck, Adaptive trial design methodology and software demons
-
VPLive Vape Team Episode #39: Sponsored by Pfizer?
On this episode, "Sponsored by Pfizer?" we follow the money and take an in depth look at who is really caring for your health. In the "New Vapers Corner" we take a look at the ZMAX from SmokTech, we revisit a redesigned iTaste from INNOKIN, and Michael "fieldofvapor" talks about the Volcano Lavatube V2.0. Finally we launch our 1,000+ subscriber YouTube giveaway and a special performance by CJ, th
-
DrupalCon Prague 2013: THE PFIZER STORY: BUILDING A GLOBAL DIGITAL MARKETING PLATFORM WITH DRUPAL
Managing an individual site is a complicated business. Managing hundreds of digital marketing sites across 46 countries is...the extreme. Faced with an alrea...
-
Big Pharma ► Episode 4 ► Ready to take on Pfizer! - Intermediate Mastery Series!
Big Pharma Gameplay- Beta 0.40.04 - What's better than an amazing cure for one of the worlds most debilitating male inconveniences?! A cure for a REAL disease!
Introducing the world where all of the pharmaceuticals get produced for use with Theme Hospital, Hospital Tycoon, and Surgeon Simulator. It's a good thing too, because we've all been that careless administrator that encourage the easy dist
-
The Royal Society Award donne le prix Pfizer au docteur Muyembe-Tamfum à Londres
-
How Pfizer standardised incentive compensation plans globally
Jeffrey LiPira, Global Program Manager, Pfizer speaking at eyeforpharma Barcelona 2014 on how Pfizer standardised incentive compensation plans globally. eyef...
-
Pfizer's Recent Use of tranSMART
Session 3: Pfizer's Recent Use of tranSMART Over the past months Pfizer has expanded the tranSMART footprint to include the Neuroscience Research Unit by inc...
-
Pfizer Jeddah, Saudi Arabia Iftar 2014
Pfizer Jeddah, Saudi Arabia Iftar 2014 July 10, 2014 Crowne Plaza Jeddah Saudi Arabia #ecgatchie #iftar #pfizersaudi #pfizer #happy #crowneplazajeddah #crown...
-
Going Underground: Pfizer's failed bid & Internet kills the TV star (E85)
Afshin Rattansi goes underground on recent calls to nationalise AstraZeneca, after Pfizer backed out of its controversial takeover bid. MP Kelvin Hopkins, le...
-
DrupalCon Prague 2013: WF TOOLS FTW @ PFIZER
For years people have complained about Drupal's lack of dev-stage-prod workflow. Most of the solutions either solve the the content part of the problem or ha...
-
Where Pfizer's Director Of Innovation Sees The Clinical Research Industry Headed
Where Pfizer's Director Of Innovation Sees The Clinical Research Industry Headed
http://www.TheClinicalTrialsGuru.com
-
AstraZenaca Finally Rejects Pfizer | Market Checkup - 5/19/14 | The Motley Fool
Investing made simple: The Motley Fool's essential guide to investing is now available to the public, free of cost, at http://bit.ly/1atRpHZ. This resource w...
-
ΚΑΡΑΜΑΝΛΙΔΗΣ ΓΕΩΡΓΙΟΣ. Από "βοσκός" ερευνητής στο Harvard και ... στη Pfizer !
ΚΑΡΑΜΑΝΛΙΔΗΣ ΓΕΩΡΓΙΟΣ.
Από "βοσκός" ερευνητής στα καλύτερα πανεπιστήμια του κόσμου... Harvard και νυν διευθυντής ερευνητικού εργαστηρίου στη Pfizer !!!
-
Брендятина: История бренда Pfizer 31.05.2011
-
Pfizer on India compulsory licenses at March 13, 2013 hearing
These are excerpts from a March 13, 2013 House Ways and Means Hearing on "U.S.-India Trade Relations: Opportunities and Challenges," including several exchan...
-
Health And Safety Threatened At Pfizer: Stop Injuring Biotech Workers!
On September 29, 2011 injured workers including former Pfizer injured molecular biologist bitotech scientist Becky McClain held a rally for justice outside t...
-
Sergio Rotstein (Pfizer): HELM standard for macromolecular representation & Pistoia Alliance
The recent increase in utilization of complex macromolecules such as Antibody-Drug Conjugates (ADCs) as therapeutic agents has revealed a substantial gap in ...
-
Behind DEKALB-Pfizer Genetics (1989)
An explanation of the business side of the seed industry. Participants in this film include, Joey Mullican, Dr. Dick Bohling, Dr. Dave Smith, Dr. Tom Hilliso...
The Binding of Isaac: Rebirth - Let's Play - Episode 374 [Pfizer]
Seed: TPHE VKA0
Subscribe to my channel for more gaming videos!: http://bit.ly/Northernlion
If you enjoyed the video, please consider hitting the Like button...
Seed: TPHE VKA0
Subscribe to my channel for more gaming videos!: http://bit.ly/Northernlion
If you enjoyed the video, please consider hitting the Like button. It helps me out a lot!
Follow me on Twitter: http://twitter.com/NorthernlionLP
Follow me on Facebook: http://facebook.com/Northernlion
As Northernlion, I produce a variety of gaming content for YouTube every single day. Be sure to tune in if you're interested in reviews, previews, first impressions videos, gameplay, walkthroughs, and playthroughs of new releases, my favorite classic games, as well as my favorites from the world of indie gaming. Thanks for watching (and reading this description!) and I hope I'll see you again.
wn.com/The Binding Of Isaac Rebirth Let's Play Episode 374 Pfizer
Seed: TPHE VKA0
Subscribe to my channel for more gaming videos!: http://bit.ly/Northernlion
If you enjoyed the video, please consider hitting the Like button. It helps me out a lot!
Follow me on Twitter: http://twitter.com/NorthernlionLP
Follow me on Facebook: http://facebook.com/Northernlion
As Northernlion, I produce a variety of gaming content for YouTube every single day. Be sure to tune in if you're interested in reviews, previews, first impressions videos, gameplay, walkthroughs, and playthroughs of new releases, my favorite classic games, as well as my favorites from the world of indie gaming. Thanks for watching (and reading this description!) and I hope I'll see you again.
- published: 19 Mar 2015
- views: 35191
Dave Cagney - Pfizer Newbridge
Dave Cagney of Pfizer Newbridge speaks at the 2015 National Manufacturing and Supply Chain Conference & Exhibition.
http://www.prempub.com...
Dave Cagney of Pfizer Newbridge speaks at the 2015 National Manufacturing and Supply Chain Conference & Exhibition.
http://www.prempub.com
wn.com/Dave Cagney Pfizer Newbridge
Dave Cagney of Pfizer Newbridge speaks at the 2015 National Manufacturing and Supply Chain Conference & Exhibition.
http://www.prempub.com
- published: 16 Apr 2015
- views: 1
Reimagine operations with analytics, technology and process innovation The Pfizer story
Reimagining processes requires a combination of domain expertise, operational prowess, a deep understanding of the desired business outcomes, and smart applicat...
Reimagining processes requires a combination of domain expertise, operational prowess, a deep understanding of the desired business outcomes, and smart application of analytics and technology.
Mark Harf, Center of Excellence Lead for Pfizer’s Global Commercial Operations, and Paul Burton, SVP and Business Leader for Analytics at Genpact, are pioneering industry-leading practices in their organizations to drive discontinuous gains in business processes.
View this webinar to to discover how Pfizer is managing innovative processes and programs that industrialize the operating environment and feed key insights back into its commercial operations, and how Genpact is enabling companies embed the right mix of analytics and technology into processes to take operations to a whole new level of intelligence.
wn.com/Reimagine Operations With Analytics, Technology And Process Innovation The Pfizer Story
Reimagining processes requires a combination of domain expertise, operational prowess, a deep understanding of the desired business outcomes, and smart application of analytics and technology.
Mark Harf, Center of Excellence Lead for Pfizer’s Global Commercial Operations, and Paul Burton, SVP and Business Leader for Analytics at Genpact, are pioneering industry-leading practices in their organizations to drive discontinuous gains in business processes.
View this webinar to to discover how Pfizer is managing innovative processes and programs that industrialize the operating environment and feed key insights back into its commercial operations, and how Genpact is enabling companies embed the right mix of analytics and technology into processes to take operations to a whole new level of intelligence.
- published: 06 Oct 2015
- views: 2
PF-06252616 (Anti-Myostatin) Webinar [June 2015]
On June 3, 2015, Dr. Michael Binks, Vice President for Rare Disease Clinical Research at Pfizer, presented information about the upcoming clinical trial of PF-...
On June 3, 2015, Dr. Michael Binks, Vice President for Rare Disease Clinical Research at Pfizer, presented information about the upcoming clinical trial of PF-06252616. The webinar provides an overview of Pfizer’s approach to advancing the science of an anti-myostatin monoclonal antibody as an investigational compound for potential therapeutic use in muscle wasting diseases, such as Duchenne muscular dystrophy. Dr. Binks gives a presentation and answers submitted questions.
wn.com/Pf 06252616 (Anti Myostatin) Webinar June 2015
On June 3, 2015, Dr. Michael Binks, Vice President for Rare Disease Clinical Research at Pfizer, presented information about the upcoming clinical trial of PF-06252616. The webinar provides an overview of Pfizer’s approach to advancing the science of an anti-myostatin monoclonal antibody as an investigational compound for potential therapeutic use in muscle wasting diseases, such as Duchenne muscular dystrophy. Dr. Binks gives a presentation and answers submitted questions.
- published: 24 Jun 2015
- views: 32
Designing Proof-of-Concept Clinical Trials - Ashwin Gollerkeri, M.D.
Innovations in statistics, programming and data management are changing the very nature of clinical development. Cytel thought-leaders reveal cutting-edge tech...
Innovations in statistics, programming and data management are changing the very nature of clinical development. Cytel thought-leaders reveal cutting-edge techniques that streamline and truly accelerate product developmental at the clinical trial, program and portfolio level.
Featuring, Simulation and biomarkers speeding development at Merck, Adaptive trial design methodology and software demonstrations, Leading independent authorities and Cytel speakers at User Group Meetings.
www.cytel.com
+1 .617.661.2011
wn.com/Designing Proof Of Concept Clinical Trials Ashwin Gollerkeri, M.D.
Innovations in statistics, programming and data management are changing the very nature of clinical development. Cytel thought-leaders reveal cutting-edge techniques that streamline and truly accelerate product developmental at the clinical trial, program and portfolio level.
Featuring, Simulation and biomarkers speeding development at Merck, Adaptive trial design methodology and software demonstrations, Leading independent authorities and Cytel speakers at User Group Meetings.
www.cytel.com
+1 .617.661.2011
- published: 06 Nov 2014
- views: 0
VPLive Vape Team Episode #39: Sponsored by Pfizer?
On this episode, "Sponsored by Pfizer?" we follow the money and take an in depth look at who is really caring for your health. In the "New Vapers Corner" we ta...
On this episode, "Sponsored by Pfizer?" we follow the money and take an in depth look at who is really caring for your health. In the "New Vapers Corner" we take a look at the ZMAX from SmokTech, we revisit a redesigned iTaste from INNOKIN, and Michael "fieldofvapor" talks about the Volcano Lavatube V2.0. Finally we launch our 1,000+ subscriber YouTube giveaway and a special performance by CJ, the Vaping Monkey! Check it out!
Shout Outs:
Thanks to Michael aka FieldofVapor for coming on and discussing the Smoktech ZMAX and Volcano Lavatube V2.0. Check out his YouTube Channel @ http://www.youtube.com/fieldofvapor
Thanks to all of our subscribers who pushed us above 1,000 subscribers! Please tell your friends about the VapeTeam! We love our viewers!
Please support a fellow vaper, Jennifer Cook, who is currently affected by DICS breast cancer. Please donate and help out a woman who has been influential in shaping the vaping community. http://bit.ly/jencancerfund
Bit.ly Bookmarks Bundle for this show, links to everything we talked about, including Vapemeets: http://bitly.com/bundles/o_26fc4nhmgh/9
Thanks to the vendors that provided us prizes for tonight's rapid fire trivia round of the Vape Wheel:
AvidVaper @ http://www.avidvaper.com
Awesome Clouds @ http://www.awesomeclouds.com
Carolina Vapes @ http://www.carolinavapes.com
Clouds of Vapor @ http://www.cloudsofvapor.com
Delaware Vapor @ http://www.delawarevapor.com/
NHaler @ http://www.nhaler.com
PBDragon @ http://www.pbdragon.com
Smartvapes @ http://www.smartvapes.com
New Vapers Corner:
Information of the SmokTech ZMAX:
http://www.e-cigarette-forum.com/forum/smoktech-max-vv-devices/327390-smoktech-zmax-owners-pics-tips-tricks-quirks.html
http://www.vapersforum.com/showthread.php?p=1001793
Information on the Innokin iTaste:
http://www.innokin.com/best-variable-voltage-e-cigarette.html
In The News:
MedicalXpress: Experts warn that e-cigarettes can damage the lungs
http://medicalxpress.com/news/2012-09-experts-e-cigarettes-lungs.html#jCp
Tobacco Induced Diseases: Varenicline as a smoking cessation aid in a Greek population: a subanalysis of an observational study
http://www.tobaccoinduceddiseases.com/content/10/1/1/
BBC News: Proof lacking on e-cigarettes' safety, experts warn
http://news.bbc.co.uk/2/hi/health/8467797.stm
MedicalXpress: Electronic cigarettes do not damage the heart
http://medicalxpress.com/news/2012-08-electronic-cigarettes-heart.html#jCp
PharmaTimes: Do not touch e-cigarettes, say lung experts
http://www.pharmatimes.com/Article/12-09-03/Do_not_touch_e-cigarettes_say_lung_experts.aspx
Support the organization that is helping us fight for our right to vape: CASAA @ http://www.casaa.org and the "We Are Vapers" documentary - http://www.wearevapers.com, please donate!
Thanks for watching the Vape Team! Please check out our website at http://www.vapeteam.com and catch us live at 9:30PM ET on Wednesday.
DISCLAIMER:
VPLive Vape Team is an opinion based video talk show and podcast about the vaping and electronic cigarette community. As such, all views and opinions expressed herein, regardless of authorship, do not represent the views or opinions of any presenter's employer or people, institutions or organizations that the presenter may or may not be related to or affiliated with unless explicitly stated otherwise. All contributors on VPLive Vape Team are non paid, independent vapers, or when specifically stated, representatives of electronic cigarette vendors.
The only purpose of this program is to educate and to inform. It is no substitute for professional care by a doctor or other qualified medical professional. This program is provided on the understanding that it does not constitute medical or other professional advice or services. Instead, we encourage you to discuss your options with your healthcare provider.
This podcast is intended to be viewed by adults of legal smoking age. It is not intended for viewers under the age of 18.
wn.com/Vplive Vape Team Episode 39 Sponsored By Pfizer
On this episode, "Sponsored by Pfizer?" we follow the money and take an in depth look at who is really caring for your health. In the "New Vapers Corner" we take a look at the ZMAX from SmokTech, we revisit a redesigned iTaste from INNOKIN, and Michael "fieldofvapor" talks about the Volcano Lavatube V2.0. Finally we launch our 1,000+ subscriber YouTube giveaway and a special performance by CJ, the Vaping Monkey! Check it out!
Shout Outs:
Thanks to Michael aka FieldofVapor for coming on and discussing the Smoktech ZMAX and Volcano Lavatube V2.0. Check out his YouTube Channel @ http://www.youtube.com/fieldofvapor
Thanks to all of our subscribers who pushed us above 1,000 subscribers! Please tell your friends about the VapeTeam! We love our viewers!
Please support a fellow vaper, Jennifer Cook, who is currently affected by DICS breast cancer. Please donate and help out a woman who has been influential in shaping the vaping community. http://bit.ly/jencancerfund
Bit.ly Bookmarks Bundle for this show, links to everything we talked about, including Vapemeets: http://bitly.com/bundles/o_26fc4nhmgh/9
Thanks to the vendors that provided us prizes for tonight's rapid fire trivia round of the Vape Wheel:
AvidVaper @ http://www.avidvaper.com
Awesome Clouds @ http://www.awesomeclouds.com
Carolina Vapes @ http://www.carolinavapes.com
Clouds of Vapor @ http://www.cloudsofvapor.com
Delaware Vapor @ http://www.delawarevapor.com/
NHaler @ http://www.nhaler.com
PBDragon @ http://www.pbdragon.com
Smartvapes @ http://www.smartvapes.com
New Vapers Corner:
Information of the SmokTech ZMAX:
http://www.e-cigarette-forum.com/forum/smoktech-max-vv-devices/327390-smoktech-zmax-owners-pics-tips-tricks-quirks.html
http://www.vapersforum.com/showthread.php?p=1001793
Information on the Innokin iTaste:
http://www.innokin.com/best-variable-voltage-e-cigarette.html
In The News:
MedicalXpress: Experts warn that e-cigarettes can damage the lungs
http://medicalxpress.com/news/2012-09-experts-e-cigarettes-lungs.html#jCp
Tobacco Induced Diseases: Varenicline as a smoking cessation aid in a Greek population: a subanalysis of an observational study
http://www.tobaccoinduceddiseases.com/content/10/1/1/
BBC News: Proof lacking on e-cigarettes' safety, experts warn
http://news.bbc.co.uk/2/hi/health/8467797.stm
MedicalXpress: Electronic cigarettes do not damage the heart
http://medicalxpress.com/news/2012-08-electronic-cigarettes-heart.html#jCp
PharmaTimes: Do not touch e-cigarettes, say lung experts
http://www.pharmatimes.com/Article/12-09-03/Do_not_touch_e-cigarettes_say_lung_experts.aspx
Support the organization that is helping us fight for our right to vape: CASAA @ http://www.casaa.org and the "We Are Vapers" documentary - http://www.wearevapers.com, please donate!
Thanks for watching the Vape Team! Please check out our website at http://www.vapeteam.com and catch us live at 9:30PM ET on Wednesday.
DISCLAIMER:
VPLive Vape Team is an opinion based video talk show and podcast about the vaping and electronic cigarette community. As such, all views and opinions expressed herein, regardless of authorship, do not represent the views or opinions of any presenter's employer or people, institutions or organizations that the presenter may or may not be related to or affiliated with unless explicitly stated otherwise. All contributors on VPLive Vape Team are non paid, independent vapers, or when specifically stated, representatives of electronic cigarette vendors.
The only purpose of this program is to educate and to inform. It is no substitute for professional care by a doctor or other qualified medical professional. This program is provided on the understanding that it does not constitute medical or other professional advice or services. Instead, we encourage you to discuss your options with your healthcare provider.
This podcast is intended to be viewed by adults of legal smoking age. It is not intended for viewers under the age of 18.
- published: 06 Sep 2012
- views: 3014
DrupalCon Prague 2013: THE PFIZER STORY: BUILDING A GLOBAL DIGITAL MARKETING PLATFORM WITH DRUPAL
Managing an individual site is a complicated business. Managing hundreds of digital marketing sites across 46 countries is...the extreme. Faced with an alrea......
Managing an individual site is a complicated business. Managing hundreds of digital marketing sites across 46 countries is...the extreme. Faced with an alrea...
wn.com/Drupalcon Prague 2013 The Pfizer Story Building A Global Digital Marketing Platform With Drupal
Managing an individual site is a complicated business. Managing hundreds of digital marketing sites across 46 countries is...the extreme. Faced with an alrea...
Big Pharma ► Episode 4 ► Ready to take on Pfizer! - Intermediate Mastery Series!
Big Pharma Gameplay- Beta 0.40.04 - What's better than an amazing cure for one of the worlds most debilitating male inconveniences?! A cure for a REAL disease!
...
Big Pharma Gameplay- Beta 0.40.04 - What's better than an amazing cure for one of the worlds most debilitating male inconveniences?! A cure for a REAL disease!
Introducing the world where all of the pharmaceuticals get produced for use with Theme Hospital, Hospital Tycoon, and Surgeon Simulator. It's a good thing too, because we've all been that careless administrator that encourage the easy distribution of fix-it-all one step cures for everything.
If you want to learn more about the Big Pharma and Twice Circled Games, you can visit their web page here:
http://www.bigpharmagame.com/
To keep up with my new videos subscribe to my channel here:
https://www.youtube.com/user/DeluksGaming
Or my new Facebook page here:
https://www.facebook.com/pages/Deluks-Gaming/376236832543279
Or visit me on my new twitter channel at:
https://twitter.com/DeluksGaming
****************************************************
Some music in this episode was provided by:
Kevin MacLeod (incompetech.com)
Licensed under Creative Commons: By Attribution 3.0
http://creativecommons.org/licenses/by/3.0/
"Latin Industries"
****************************************************
What is Big Pharma?
is part business sim, part logistics puzzle. It’s one thing to work away in the lab perfecting new formulas, but converting the ‘sciency stuff’ into cold hard cash means bringing an engineering and business mind to the problem.
Factory space is expensive, and those fancy new agglomerators and centrifuges don’t always slot nicely together.
With a few rusty reconditioned machines, you can progress from knocking out cheap generic treatments for minor ailments, to discovering new active ingredients and hi-tech machines to help refine the next generation of world-changing drugs.
But watch out, you’re not alone out there. Rival corporations that want to put you out of business have their own set of competing cures and treatments.
Then there’s the dynamically shifting marketplace which means that your fancy cold and flu medicine from last winter might not sell so well now it’s the height of summer. Where did I put my anti-wrinkle sun cream?
wn.com/Big Pharma ► Episode 4 ► Ready To Take On Pfizer Intermediate Mastery Series
Big Pharma Gameplay- Beta 0.40.04 - What's better than an amazing cure for one of the worlds most debilitating male inconveniences?! A cure for a REAL disease!
Introducing the world where all of the pharmaceuticals get produced for use with Theme Hospital, Hospital Tycoon, and Surgeon Simulator. It's a good thing too, because we've all been that careless administrator that encourage the easy distribution of fix-it-all one step cures for everything.
If you want to learn more about the Big Pharma and Twice Circled Games, you can visit their web page here:
http://www.bigpharmagame.com/
To keep up with my new videos subscribe to my channel here:
https://www.youtube.com/user/DeluksGaming
Or my new Facebook page here:
https://www.facebook.com/pages/Deluks-Gaming/376236832543279
Or visit me on my new twitter channel at:
https://twitter.com/DeluksGaming
****************************************************
Some music in this episode was provided by:
Kevin MacLeod (incompetech.com)
Licensed under Creative Commons: By Attribution 3.0
http://creativecommons.org/licenses/by/3.0/
"Latin Industries"
****************************************************
What is Big Pharma?
is part business sim, part logistics puzzle. It’s one thing to work away in the lab perfecting new formulas, but converting the ‘sciency stuff’ into cold hard cash means bringing an engineering and business mind to the problem.
Factory space is expensive, and those fancy new agglomerators and centrifuges don’t always slot nicely together.
With a few rusty reconditioned machines, you can progress from knocking out cheap generic treatments for minor ailments, to discovering new active ingredients and hi-tech machines to help refine the next generation of world-changing drugs.
But watch out, you’re not alone out there. Rival corporations that want to put you out of business have their own set of competing cures and treatments.
Then there’s the dynamically shifting marketplace which means that your fancy cold and flu medicine from last winter might not sell so well now it’s the height of summer. Where did I put my anti-wrinkle sun cream?
- published: 12 Jun 2015
- views: 371
How Pfizer standardised incentive compensation plans globally
Jeffrey LiPira, Global Program Manager, Pfizer speaking at eyeforpharma Barcelona 2014 on how Pfizer standardised incentive compensation plans globally. eyef......
Jeffrey LiPira, Global Program Manager, Pfizer speaking at eyeforpharma Barcelona 2014 on how Pfizer standardised incentive compensation plans globally. eyef...
wn.com/How Pfizer Standardised Incentive Compensation Plans Globally
Jeffrey LiPira, Global Program Manager, Pfizer speaking at eyeforpharma Barcelona 2014 on how Pfizer standardised incentive compensation plans globally. eyef...
Pfizer's Recent Use of tranSMART
Session 3: Pfizer's Recent Use of tranSMART Over the past months Pfizer has expanded the tranSMART footprint to include the Neuroscience Research Unit by inc......
Session 3: Pfizer's Recent Use of tranSMART Over the past months Pfizer has expanded the tranSMART footprint to include the Neuroscience Research Unit by inc...
wn.com/Pfizer's Recent Use Of Transmart
Session 3: Pfizer's Recent Use of tranSMART Over the past months Pfizer has expanded the tranSMART footprint to include the Neuroscience Research Unit by inc...
Pfizer Jeddah, Saudi Arabia Iftar 2014
Pfizer Jeddah, Saudi Arabia Iftar 2014 July 10, 2014 Crowne Plaza Jeddah Saudi Arabia #ecgatchie #iftar #pfizersaudi #pfizer #happy #crowneplazajeddah #crown......
Pfizer Jeddah, Saudi Arabia Iftar 2014 July 10, 2014 Crowne Plaza Jeddah Saudi Arabia #ecgatchie #iftar #pfizersaudi #pfizer #happy #crowneplazajeddah #crown...
wn.com/Pfizer Jeddah, Saudi Arabia Iftar 2014
Pfizer Jeddah, Saudi Arabia Iftar 2014 July 10, 2014 Crowne Plaza Jeddah Saudi Arabia #ecgatchie #iftar #pfizersaudi #pfizer #happy #crowneplazajeddah #crown...
Going Underground: Pfizer's failed bid & Internet kills the TV star (E85)
Afshin Rattansi goes underground on recent calls to nationalise AstraZeneca, after Pfizer backed out of its controversial takeover bid. MP Kelvin Hopkins, le......
Afshin Rattansi goes underground on recent calls to nationalise AstraZeneca, after Pfizer backed out of its controversial takeover bid. MP Kelvin Hopkins, le...
wn.com/Going Underground Pfizer's Failed Bid Internet Kills The Tv Star (E85)
Afshin Rattansi goes underground on recent calls to nationalise AstraZeneca, after Pfizer backed out of its controversial takeover bid. MP Kelvin Hopkins, le...
DrupalCon Prague 2013: WF TOOLS FTW @ PFIZER
For years people have complained about Drupal's lack of dev-stage-prod workflow. Most of the solutions either solve the the content part of the problem or ha......
For years people have complained about Drupal's lack of dev-stage-prod workflow. Most of the solutions either solve the the content part of the problem or ha...
wn.com/Drupalcon Prague 2013 Wf Tools Ftw Pfizer
For years people have complained about Drupal's lack of dev-stage-prod workflow. Most of the solutions either solve the the content part of the problem or ha...
Where Pfizer's Director Of Innovation Sees The Clinical Research Industry Headed
Where Pfizer's Director Of Innovation Sees The Clinical Research Industry Headed
http://www.TheClinicalTrialsGuru.com...
Where Pfizer's Director Of Innovation Sees The Clinical Research Industry Headed
http://www.TheClinicalTrialsGuru.com
wn.com/Where Pfizer's Director Of Innovation Sees The Clinical Research Industry Headed
Where Pfizer's Director Of Innovation Sees The Clinical Research Industry Headed
http://www.TheClinicalTrialsGuru.com
- published: 30 May 2015
- views: 42
AstraZenaca Finally Rejects Pfizer | Market Checkup - 5/19/14 | The Motley Fool
Investing made simple: The Motley Fool's essential guide to investing is now available to the public, free of cost, at http://bit.ly/1atRpHZ. This resource w......
Investing made simple: The Motley Fool's essential guide to investing is now available to the public, free of cost, at http://bit.ly/1atRpHZ. This resource w...
wn.com/Astrazenaca Finally Rejects Pfizer | Market Checkup 5 19 14 | The Motley Fool
Investing made simple: The Motley Fool's essential guide to investing is now available to the public, free of cost, at http://bit.ly/1atRpHZ. This resource w...
ΚΑΡΑΜΑΝΛΙΔΗΣ ΓΕΩΡΓΙΟΣ. Από "βοσκός" ερευνητής στο Harvard και ... στη Pfizer !
ΚΑΡΑΜΑΝΛΙΔΗΣ ΓΕΩΡΓΙΟΣ.
Από "βοσκός" ερευνητής στα καλύτερα πανεπιστήμια του κόσμου... Harvard και νυν διευθυντής ερευνητικού εργαστηρίου στη Pfizer !!!...
ΚΑΡΑΜΑΝΛΙΔΗΣ ΓΕΩΡΓΙΟΣ.
Από "βοσκός" ερευνητής στα καλύτερα πανεπιστήμια του κόσμου... Harvard και νυν διευθυντής ερευνητικού εργαστηρίου στη Pfizer !!!
wn.com/Καραμανλιδησ Γεωργιοσ. Από Βοσκός Ερευνητής Στο Harvard Και ... Στη Pfizer
ΚΑΡΑΜΑΝΛΙΔΗΣ ΓΕΩΡΓΙΟΣ.
Από "βοσκός" ερευνητής στα καλύτερα πανεπιστήμια του κόσμου... Harvard και νυν διευθυντής ερευνητικού εργαστηρίου στη Pfizer !!!
- published: 15 Mar 2015
- views: 195
Pfizer on India compulsory licenses at March 13, 2013 hearing
These are excerpts from a March 13, 2013 House Ways and Means Hearing on "U.S.-India Trade Relations: Opportunities and Challenges," including several exchan......
These are excerpts from a March 13, 2013 House Ways and Means Hearing on "U.S.-India Trade Relations: Opportunities and Challenges," including several exchan...
wn.com/Pfizer On India Compulsory Licenses At March 13, 2013 Hearing
These are excerpts from a March 13, 2013 House Ways and Means Hearing on "U.S.-India Trade Relations: Opportunities and Challenges," including several exchan...
- published: 25 Mar 2013
- views: 502
-
author: KEIWashDC
Health And Safety Threatened At Pfizer: Stop Injuring Biotech Workers!
On September 29, 2011 injured workers including former Pfizer injured molecular biologist bitotech scientist Becky McClain held a rally for justice outside t......
On September 29, 2011 injured workers including former Pfizer injured molecular biologist bitotech scientist Becky McClain held a rally for justice outside t...
wn.com/Health And Safety Threatened At Pfizer Stop Injuring Biotech Workers
On September 29, 2011 injured workers including former Pfizer injured molecular biologist bitotech scientist Becky McClain held a rally for justice outside t...
- published: 27 Sep 2011
- views: 1211
-
author: laborvideo
Sergio Rotstein (Pfizer): HELM standard for macromolecular representation & Pistoia Alliance
The recent increase in utilization of complex macromolecules such as Antibody-Drug Conjugates (ADCs) as therapeutic agents has revealed a substantial gap in ......
The recent increase in utilization of complex macromolecules such as Antibody-Drug Conjugates (ADCs) as therapeutic agents has revealed a substantial gap in ...
wn.com/Sergio Rotstein (Pfizer) Helm Standard For Macromolecular Representation Pistoia Alliance
The recent increase in utilization of complex macromolecules such as Antibody-Drug Conjugates (ADCs) as therapeutic agents has revealed a substantial gap in ...
- published: 05 Jun 2013
- views: 190
-
author: Chem Axon
Behind DEKALB-Pfizer Genetics (1989)
An explanation of the business side of the seed industry. Participants in this film include, Joey Mullican, Dr. Dick Bohling, Dr. Dave Smith, Dr. Tom Hilliso......
An explanation of the business side of the seed industry. Participants in this film include, Joey Mullican, Dr. Dick Bohling, Dr. Dave Smith, Dr. Tom Hilliso...
wn.com/Behind Dekalb Pfizer Genetics (1989)
An explanation of the business side of the seed industry. Participants in this film include, Joey Mullican, Dr. Dick Bohling, Dr. Dave Smith, Dr. Tom Hilliso...